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ABSTRACT 
 
JENNIFER LYNN SZCZYTKOWSKI: Conditioned Effects of Heroin on 
Proinflammatory Mediators 
(Under the direction of Donald T. Lysle, Ph.D.) 
 
 Heroin administration alters the induction of nitric oxide, a molecule known to 
play a critical role in immune function, as well as the production of several 
proinflammatory cytokines including tumor necrosis factor-alpha (TNF-α) and 
interleukin-one beta (IL-1β).  Previous research has shown that these alterations can 
be conditioned to environmental stimuli that have been associated with drug 
administration.  The investigations presented here deal with the neural mechanisms 
whereby these drug cues alter the expression and production of certain 
proinflammatory mediators essential for host defense.  The experiments in Chapter 2 
demonstrate that the conditioned alterations in proinflammatory mediators induced by 
exposure to previously heroin-paired stimuli are a true form of associative learning as 
they are susceptible to both extinction and latent inhibition.  Chapter 3 reveals that the 
basolateral amygdala (BLA), an area of the brain which has been implicated in the 
formation of stimulus-reward associations within models of drug abuse, is necessary for 
the expression of the conditioned response.  Administration of a combination of the 
GABA agonists, muscimol and baclofen, directly into the BLA blocked the 
conditioned suppression of proinflammatory mediators while administration of these 
same drugs into an adjacent region of the caudate did not alter the response.  The 
experiments outlined in Chapter 4 show that the pharmacological blockade dopamine, 
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D1 receptors in the BLA reverses the conditioned suppression induced by exposure to 
previously heroin-paired stimuli.  The administration of the dopamine D1 antagonist, 
SCH23390, but not the D2 antagonist, raclopride, resulted in attenuation of the 
conditioned effect.  These studies are important because they are the first to 
investigate the neural circuitry involved in the conditioned immune alterations 
produced by exposure to drug cues.  Overall, these findings indicate a need to 
consider the implications of exposure to drug cues on the immune functioning of  
current and recovering heroin use.
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CHAPTER 1 
GENERAL INTRODUCTION 
 
A Brief History of Heroin & Heroin Use  
 
 Heroin, or diacetylmorphine, is a semisynthetic derivative of morphine and a 
member of the class of drugs known as opiates.  Opiates include any of various 
sedative narcotics found in opium or any natural or synthetic derivatives thereof.  
Opium is found in the dried sap of the opium poppy and naturally contains over two 
dozen alkaloids, including morphine and codeine.  The opium poppy, Papaver 
somniferum, is one of over 250 species of poppy plants and derives its name from the 
latin word for ‘sleep inducing’.  It is unknown whether the P. somniferum plant 
naturally evolved from another species of poppy, such as the Papaver setigerum 
which contains minute amounts of opium, or whether it was specifically cultivated 
and bred by humans to maximize the plant’s narcotic effects.  It is also a mystery as to 
why the plant would produce the alkaloid substance at all.  Theories suggest that the 
opium may aid in the production of the poppy plants’ seeds or that it protects the plant 
from unwanted predators.  Perhaps the most intriguing theory of all claims that the 
opium poppy produces the addictive medicinal substance to ensure its continued 
human cultivation (Booth, 1996).   
 Some of the first recorded evidence of opium cultivation comes from the 
history of the Sumerian culture.  The Sumerians are credited with developing the first 
form of writing around 3300 BC and it is from their writings that we first learn of the 
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opium poppy and its use both medicinally and recreationally.  The Sumerians referred 
to the plant as hul gil or ‘plant of joy’ and as time passed the secrets of opium 
cultivation were shared with neighboring civilizations thus allowing for its 
introduction into cultures such as those of the Syrians, Egyptians and Greeks.  
Although the Sumerians were the among the first to record their interaction with the 
opium poppy it is possible that the origins of its use reach much further back into 
history.  Cultivated seeds from the P. Somniferum poppy were among the items 
discovered at the site of a 4500 year old Cortaillod village in Switzerland though we 
know little of how the plant was used by the villagers.  The oldest known physical 
evidence of opium cultivation was found at the 7700 year old site of La Marmotta in 
Italy.  Here archaelogists uncovered P. Somniferum seeds alongside items believed to 
be used for religious purposes suggesting the plant might have been a component of 
spiritual life for these Neolithic farmers (Merlin, 2003).   
 While medicinal opium use was already widespread by the second millenium,  
Mithridates VI of Pontus (134-63 BC) is credited with concocting one of the first 
known opium containing medicines which was aptly named ‘mithridate’.  Mithridate 
contained over forty ingredients including opium, saffron, myrrh, castor, ginger and 
cinnamon and was hailed as an omnipotent antidote for everything from snakebites to 
poisoning.  In fact, according to legend Mithridates VI regularly ingested his cure-all 
to guard against assassination attempts.  The composition of mithridate was later 
altered by Andromachus, physician to emperor Nero (37-68 AD), and the new 
formula became known as theriac.  For hundreds of years opium was treated almost as 
a panacea and was prescribed by doctors to treat ailments ranging from kidney stones 
to morning sickeness to diarrhea.  Even the famous Greek physician Galen (129-200 
AD) prescribed mithridate to his patients “claiming it resisted poison and venomous 
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bites and cured, amongst other things, headaches, vertigo, deafness, epilepsy, 
apoplexy, poor sight, bronchitis asthma, coughs, the spitting of blood, colic, jaundice, 
hardness of the spleen, kidney stones, urinary complaints, fever, dropsy, leprosy, 
menstrual problems, melancholy and all other pestilences”(Booth, 1996).  Both 
theriac and mithridate were cited in the London Pharmacopoeia published in 1618 but 
by the 1756 publishing of the Edinburgh Pharmacopoeia had fallen from favor and 
were left out.   
 A more modern opium concoction can be traced to Thomas Sydenham, a 
physician of the seventeeth century who used a combination of alcohol and opium to 
treat disease.  The term ‘laudanum’, which is translated worthy of praise in Latin, is 
thought to have been orignally coined by the sixteenth century physician, Paracelsus.  
However, it is unknown whether Paracelsus’ version of laudanum contained opium as 
an ingredient as his formula remains a mystery (Hodgson, 2001).  The tendency to 
prescribe opium for even the most minor health complaint led to an increasing 
number of problems concerning its overuse.  In 1700, Dr. John Jones published 
„Mysteries of Opium Reveal’d“ in which he wrote about the addictive potential of 
opium stating that discontinuation of its use resulted in „great, and even intolerable 
Distresses, Anxieties and Depressions of Spirits, which in a few days commonly end 
in a most miserable Death“. Some physicians went as far as to caution that the drug 
was in fact poisonous but despite these warnings opium use continued and opium 
importation into the United States doubled between the years of 1870 and 1890 
(Courtwright, 2001).   
 The physiological effects of opium on the body are the result of its principal 
active ingredient, morphine.  These effects include analgesia, sedation, respiratory 
depression and constipation.  Morphine was originally isolated from the opium poppy 
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by the German pharmacist Friedrich Wilhelm Serturner in 1805.  His discovery was 
historical not only because of the enormous impact that morphine would have in years 
to come but also because this was the first alkaloid to ever have been isolated from a 
plant.  He named the isolated substance ‘morphium’ in reference to Morpheus, the 
Greek god of dreams because of its sleep-inducing properties.  Morphine began to 
produced commercially between 1820 and 1830, however, the drug was underutilized 
because ingestion did not have the same magnitude of effects as injection directly into 
the bloodstream.  When Dr. Alexander Wood invented the hypodermic needle in 1853 
morphine use became even more popular.  In fact, during the Civil War morphine 
syringes became a standard tool in army field hospitals for treating soldiers’ pain.  
Unfortunately, the rampant use of the drug also led to the development of huge 
numbers of soldiers turned morphine addicts (Carnwath & Smith, 2002).  In fact, it is 
believe that most of the morphine addicts of this time period had their first experience 
with the drug for medicinal purposes and continued its use long after the initial 
medical reasons warranted (Hodgson, 2001).   
 As morphine addiction began to become a rampant societal issue the quest 
began for a non-addictive alternative.  While working on this very problem in 1874, 
CR Alder Wright boiled morphine with acetic anhydride effectively altering its 
chemical structure (Wright, 1874) and creating a narcotic even more powerful and 
addictive.  Thus begins the history of heroin.  Following its initial synthesis, heroin 
was not met with much enthusiasm.  Wright invited London physician FM Pierce to 
determine the effects of this compound and others but after testing in both dogs and 
rabbits the data was found to be inconclusive (Pierce, 1874).  The chemical was tested 
again in 1888 by David Dott and Ralph Stockman at the University of Edinburgh.  
The pair reported to the British Medical Association their observed comparisons 
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between morphine and the new diacetylmorphine compound.  In their report, 
Stockman and Dott claimed that the acetylated morphine compound was more 
effective than pure morphine at depressing the respiratory centers of the test subjects 
and that high doses may result in convulsions more frequently than morphine.  They 
seemed relatively uninterested in any possible therapeutic or medicinal properties of 
diacetylmorphine on its own (Sneader, 1998).   
 It wasn’t until 1897, when Felix Hoffman and Aurthur Eichengrun set upon 
examining the compound again that its unique medicinal properties began to be 
explored.  Hoffman and Eichengrun were members of a research team set up by 
Heinrich Dreser at Bayer Pharmaceuticals to investigate the acetylation of various 
medications.  Dreser believed that the process of acetylation would lead to increased 
potency and reduced side effects of these medications.   This same team is also 
responsible for the acetylation of salicylic acid which resulted in the production of 
what we know today as aspirin.  In a series of papers, Dreser heralded the newly 
discovered properties of the compound claiming that the acetylated morphine would 
not only suppress coughing but also had the power to stimulate respiration thus 
leading to increased clearing of the lungs (Carnwath & Smith, 2002).  On the basis of 
Dreser’s reports, Bayer Pharmaceutical Company introduced heroin to the medical 
community as a cough suppressant and treatment for tuberculosis in 1898.  However, 
Dreser’s theory on the stimulatory action of heroin on the respiratory system was soon 
laid to rest.  According to the British Pharmaceutical Codex (1907), the ‘introduction 
of acid (or alkyl) groups into the morphine molecule, however, weakens, though it 
does not remove, its depressing action on the respiratory centre, and lessens its 
narcotic effect’.  In 1911, von Issekutz published results further proving that heroin 
acts as a respiratory depressant rather than a stimulant.  Furthermore, the 1911 British 
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Pharmaceutical Codex goes on to state that ‘acetomorphine [heroin] resembles 
codeine, over which it is very doubtful if it possesses any advantage’.   
 Prior to 1906, the addition of heroin and other opiates in medicinal remedies 
was mostly unregulated.  The twentieth century ushered in a new mentality 
concerning the unregulated sale and use of drugs and legislation limiting and soon 
eliminating these practices began to be passed in the United States.  In 1906 the Pure 
Food and Drug Act is enacted requiring medicines to list their ingredients.  One 
regulation that may have actually lended to the increasing number of heroin users was 
the Smoking Opium Exlusion Act of 1909 which forbade the importation of opium 
except by pharmaceutical companies.  Since opium was now only available illicitly, 
and thus expensive, many former opium users switch to heroin to feed their addiction 
because heroin was “cheaper, quicker, and much harder to detect” (Musto, 2002).  In 
1914, the Harrison Narcotic Tax Act was passed to both control and tax the 
importation, production and sale of opiates and cocaine1.  The production of heroin 
was outlawed in the United States in 1924 and the last vestiges surrendered to the 
federal government upon passage of the Narcotic Control Act of 1956.  
 Herion use continues to be a problem today.  In 2003, the National Survey on 
Drug Use and Health indicated that an estimated 3.7 million individuals had used 
heroin at some point during their lives.  The 2006 report indicated that the number of 
current heroin users rose by about forty percent between 2005 and 2006 increasing the 
prevalence rate from 0.06 to .14.  The majority of the heroin sold today is smuggled 
illegally into the United States from countries such as Afghanistan and Burma.  In 
fact, 1/3 of the Afghan economy is based on the production of opium (Department of 
State, 2008).  Studies estimate that heroin use cost the United States between $15 and 
20 billion in 1996 (Mark & Juday, 1999).  This number includes the cost of criminal 
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acts committed under the influence of heroin, lost productivity of heroin users and 
healthcare costs related to the treatment of heroin addiction and other illnesses or 
accidents related to heroin use.  These figures are startling and present a very real and 
critical rationale for furthering our understanding of heroin and its effects on the 
heroin user.   
 
The Neurobiology of Opiate Use and Addiction 
 Heroin has been characterized as a more potent and faster acting opiate than 
morphine with users reporting an intense ‘rush’ almost immediatly upon intravenous 
administration. Following inhalation or injection into the bloodstream, the presence of 
acetyl groups on the heroin molecule render it lipophilic and facilitate its rapid 
transportation across the blood brain barrier allowing for these acute physiological 
effects.  Due to its unique chemical structure, 68% of heroin administered 
intravenously will enter the brain compared with only 5% of morphine administed in 
the same manner (Oldendorf, 1972; Hartveg et al, 1984). Once within the brain, 
however, heroin undergoes deacetylation and is converted to its pharmacologically 
active metabolites morphine and 6-monoacetylmorphine1.  It is the metabolites of 
heroin, rather than heroin itself, that create the myriad of symptoms and side effects 
that are associated with heroin use (Way et al., 1960; Umans & Inturrisi, 1981; 
Inturrisi et al 1983).  For this reason, heroin is considered to be a ‘prodrug’.  Many of 
the differences in pharmocodynamics and pharmacokinetics observed between 
morphine and heroin are attributed to 6-monoacetylmorphine which is formed 
following heroin deacetylation.  Maximal concentrations of plasma 6-
                                                 
1 When administered orally, heroin deacetylation will occur in the periphery and the resulting 
physiological effects will more closely mirror those of morphine (Sawynok, 1986).   
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monoacetylmorphine are detected in less than three minutes following intravenous 
heroin administration (Rook et al., 2006) indicating a probable role for this metabolite 
in the acute physiological effects of heroin.   6-monoacetylmorphine is then further 
metabolized into morphine within thirty minutes (Umans & Inturrisi, 1981).      
 
 
Figure 1.1  Heroin (diacetylmorphine) is rapidly metabolized in the body into 6-
monoacetylmorphine which is then further metabolized into morphine. 
 
 
Opioid drugs exert their physiological effects by binding to opioid receptors 
either within the central nervous system or in the periphery.  Three classes of opioid 
receptors have been described; mu, delta and kappa.  All of the opioid receptors are 
seven transmembrane G-protein coupled receptors (GPCR).  These receptors undergo 
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a conformational change of the cytoplasmic domain upon the binding of an agonist 
thus allowing for the heterotrimeric G-protein to dissociate and alter intracellular 
signalling pathways.  The end result of these pathways may include transient changes 
in neuronal signaling and/or long term alterations in gene expression.  The major 
endogenous ligands of the opioid receptors include the three families of enkaphalin-
containing opioid neuropeptides: the endorphins2, the enkephalins3 and the 
dynorphins4.  The endorphins were originally thought to be the endogenous mu-opioid 
receptor ligand but in fact these peptides show only limited agonistic activity at the 
receptor.  Further research has revealed another class of opioid neuropeptides, the 
endomorphins, which preferentailly bind to the mu-opioid receptor with high affinity 
and specificity (Zadina et al., 1997).  Both morphine and 6-monoacetylmorphine are 
potent exogenous agonists of the mu-opioid receptor for which heroin shows only a 
slight affinity because of its unique molecular structure.  Research suggests that there 
exists a number of splice variants of the mu-opioid receptor gene which give rise to 
functional subtypes of the receptor.  For example, activity at the mu1 opioid receptors 
is associated with the analgesic properties of opioid drugs while activity at mu2 
receptors is responsible for gastrointestinal and respiratory suppression, euphoric 
feelings and physical dependence (Schwartz, 1998).  In addition to the mu-opioid 
receptor, the agonist activity of 6-monoacetylmorphine at the delta-opioid receptor in 
both the brain and spinal cord may play a role in heroin-induced analgesia (Rady et 
al., 1994). 
 Heroin, as with all drugs of abuse, activates the brain’s reward pathway.    
Research suggests that this activation is the result of disinhibition of GABA 
                                                 
2 A contraction of ‘endogenous morphine’ 
3 from the Greek words en for ‘in’ and kephale for ‘head’ 
4 An abbreviation for ‘dynamic endorphins’ 
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interneurons in the ventral tegmental area (VTA), possibly via the binding of heroin 
metabolites to the mu-opioid receptors present on these cells.  In support of this, both 
systemic and intra-VTA morphine administration results in hyperpolarization of 
interneurons and increased firing of VTA dopamine containing neurons (Johnson & 
North, 1992).  Allison et al. (2006) demonstrated that the GABA interneurons of the 
VTA communicate via connexin-36 gap junctions allowing for rapid excitatory 
activity between neighboring cells.  Furthermore, it appears that signalling via these 
gap junctions may be inhibited by activation of their mu-opioid receptors as systemic 
heroin administration, similar to the application of gap junction blockers, reduces IC-
evoked post-stimulus spike discharges of the VTA GABA interneurons (Steffenson et 
al., 2006).  Therefore, the binding of heroin metabolites to mu-opioid receptors on 
GABA interneurons in the VTA may induce changes in these neurons that result in 
the inhibition of the gap junctions.  This leads to the hyperpolarization of these cells 
and reduces the inhibitory GABA signal that allows for increased firing of the 
dopaminergic neurons.  As a result of increased VTA dopaminergic neuronal activity, 
dopamine release in VTA target regions such as the nucleus accumbens and prefrontal 
cortex is likely to be increased (Kelly et al., 1980; Schultz, 1997).  In fact, 
microdialysis studies demonstrate increased dopamine levels in the nucleus 
accumbens following the systemic administration of morphine (Rada et al., 1991).   
 Interestingly, exposure to a stimulus that has become associated with drug use 
will also result in the firing of the VTA dopaminergic neurons and increased 
extracellular dopamine within the nucleus accumbens (Fontana et al., 1993).  In other 
words, a formerly neutral stimulus that has been paired with drug administration may 
induce neural activity similar to that seen upon actual drug administration.  This 
suggests that these drug cues may gain reinforcing properties through a learned 
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association with administration of the drug.  In addition, evidence from behavioral 
models such as the conditioned place preference test suggest that the VTA-Nacc 
pathway may play a critical role in drug addiction (Shippenberg et al., 1992).  For 
example, heroin seeking induced by a priming injection of heroin or exposure to 
stimuli previously associated with heroin use resulted in an increase in glutamate 
release in the core region of the NAcc.  Furthermore, this increase was inhibited by 
temporary inactivation of synpatic activity in the prelimbic cortex supporting the role 
of a pathway from the prelimbic region to the Nacc in drug seeking (LaLumiere & 
Kalivas, 2008).  Taken together, these data suggest that the neural circuitry involved 
in conditioned drug effects may be similar to those mediating the effects of the drug 
itself.  
 
 
The Effects of Opioids on Health Status 
 
 It is well-documented that clinically relevant opioids, like morphine, exert a 
profound influence on immune status.  Administration of morphine has been 
associated with alterations in leukocyte proliferation (Roy et al., 1996; Houghtling et 
al., 2000; Bayer et al., 1990a; Eisenstein et al., 1991), natural killer cell activity 
(Shavit et al., 1986; Bayer et al., 1990b), T cell differentiation (Roy et al., 2001) 
inflammatory responses (House et al., 2001) and antibody production (Lockwood et 
al., 1994).  Most importantly, administration of morphine has been shown to disrupt 
the innate immune system which provides the first line of defense against invading 
pathogens.  If the innate immune response is weakened, pathogens may be allowed to 
pass more readily into the body and rapidly proliferate.  For example, animals treated 
with morphine exhibit symptoms of increased gastrointestinal permeability, such as 
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the systemic dissemination of gut flora and orally ingested Salmonella (Hilburger et 
al., 1997; MacFarlane et al., 2000).  Morphine-treated animals also show a decrease in 
neutrophil chemotaxis and delayed entry of neutrophils into the alveolar 
compartments after infection with Streptococcus pneumonaie (Grimm et al., 1998; 
Wang et al., 2008).   
 In addition, the innate immune system is responsible for the induction of the 
adaptive immune response and a breakdown in the communication between these two 
systems may result in an increased vulnerability of the host to damage wrought by the 
pathogen.   For example, both morphine and heroin have been shown to alter the 
expression of cytokines such as TNF-α and IL-1β both of which are released by cells 
of the innate immune system and are involved in the facilitation of the adaptive 
immune response (Clark et al., 2007; Szczytkowski & Lysle, 2007).  Studies in our 
own laboratory have shown that acute morphine administration in rats suppresses NK 
cell activity, splenic lymphocyte proliferation in response to T- and B-cell mitogens, 
blood lymphocyte mitogenic responses, and in vitro production of the cytokines 
interleukin-2 and IFN-γ (Fecho et al., 1993; 1996 a,b; Lylse et al., 1993).  Our studies 
further show that the immune alterations induced by morphine are dose-dependent 
and antagonized by naltrexone, an opioid receptor antagonist (Fecho et al., 1996a).  
Research has suggested that the effects of opioids on immunity are mediated 
specifically via the mu-opioid receptor as antagonism of these receptors eliminates the 
immunomodulation normally seen with morphine administration (Nelson et al, 2000).  
In addition, several immune alterations normally seen with morphine treatment are 
not observed in mice lacking the mu-opioid receptor (Roy et al., 1998).   
          Although there has been extensive research on the effects of morphine on 
immune status, relatively little is known about the immunomodulatory effects of 
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heroin.  The high prevalence of opportunistic infections reported among heroin users 
has long suggested that heroin use impairs the ability of the host to combat infectious 
disease (Luttgens, 1949; Hussey & Katz, 1950; Louria et al., 1967).  Moreover, 
bacterial infections of soft tissue have been shown to account for more than one-third 
of drug-related hospital admissions, with bacteriologic data indicating that these are 
typically “mixed” infections (e.g., Orangio et al., 1984; White et al., 1973).  Bacterial 
infections associated with injection drug use can progress to major systemic infection 
and cause severe damage to tissues such as the heart and lung.  Although it has been 
postulated that this high rate of infection amongst heroin users results from increased 
contact with pathogens, possibly through needle sharing or impurities in street grade 
drugs, there is evidence that heroin may directly impact the clinical course of infection 
(Kreek, 1990; Farizio et al., 1992; McLachlan et al., 1993) and diseases associated with 
intravenous heroin use may be influenced by the ability of opioids to modulate immune 
function (McDonough et al., 1980; Donahoe et al., 1986; Novick et al., 1989; Ochshorn 
et al., 1990).  Interestingly, opioids prescribed for analgesia to burn victims and 
cardiac patients appear to influence susceptiblity to infections as higher doses of 
opiate drugs have been associated with increased infectious complications in these 
patients (El Solh et al., 2006; Schwacha et al., 2006).   These data suggest that the use 
of opioids increases the risk of infection despite the mode of administration.  In fact, 
clinical studies report abnormalities in basic immune parameters in heroin users, 
including decreased numbers of circulating lymphocytes, decreased NK cell activity, 
and reduced antibody-dependent cellular cytotoxicity (Nair et al., 1986; Govitrapong 
et al., 1998), suggesting that heroin may further contribute to increased infection 
susceptibility among users, independently of contemporaneous risk factors.  In further 
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support of this, studies have indicated that human heroin users exhibit poorer immune 
responses following hepatitis vaccination (Quaglio et al. 2004; Rodrigo et al., 1992).   
 Opiates appear to elicit immunomodulation via both central and peripheral 
mechanisms.  Research suggests that leukocytes such as dendritic cells (Li et al., 
2009), granulocytes and monocytes (Lopker et al., 1980), as well as T-lymphocytes 
(Mehrishi & Mills, 1983) all exhibit functional opioid receptors through which direct 
immunomodulation may occur.  For example, in vitro phagocytosis performed by 
macrophages is inhibited by the addition of morphine to the culture and antagonist 
studies suggest that these effects are mediated via the mu-opioid receptor (Casellas et 
al., 1991; Szabo et al., 1993).  Furthermore, morphine decreases the production of 
interferon-gamma from Con-A stimulated peripheral blood mononuclear cells and 
promotes the growth of HIV-1 in culture (Peterson et al., 1987; 1990).  Other 
evidence suggests a central mechanisms through which opiates may impact immune 
functioning.  Shavit et al. (1986) demonstrated that morphine given systemically 
induced a decrease in natural killer cell activity which was reversed upon naltrexone 
administration.  Interestingly, N-methylmorphine which does not readily cross the 
blood brain barrier and enter the CNS did not alter the activity of natural killer cells 
supporting the idea that morphine may be acting centrally to alter immune parameters.  
In addition, microinjections of opiates directly into the periaqueductal gray of rats 
induces a profound reduction in natural killer cell activity that is reversed with 
naltrexone administration (Weber & Pert, 1989).  Studies in our own laboratory have 
shown that intracerebroventricular (icv) administration of morphine dose dependently 
decreases both lymphocyte proliferation and natural killer cell cytotoxicity in the 
spleen (Lysle et al., 1996).  Furthermore, our studies have shown that N-
methylnaltrexone administered icv dose-dependently antagonizes the 
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immunomodulatory effects of systemic morphine, whereas systemic administration of 
N-methylnaltrexone (at doses that do not act centrally) is ineffective in blocking 
morphine's effects (Fecho et al., 1996a).  Taken together, these data suggest that 
opiates may alter immune functioning through both direct and indirect pathways.   
 
The Role of Proinflammatory Mediators in Immunity 
 
Although tremendous progress has been made in the understanding of how 
opioids influence immune processes, little agreement has been reached about what 
constitutes an appropriate measure of immune status.  The immune system is 
obviously complex involving a vast number of cell types and an even greater number 
of factors produced by each cell type, all of which are precisely orchestrated into a 
cascade of activity.  The experiments reported here focus on the conditioned effects of 
heroin on nitric oxide expression because of the widespread impact that nitric oxide 
has on immune function.  Studies have shown that nitric oxide is produced by many 
cells of the immune system and that it mediates diverse biological functions including 
vasodilation, the cytotoxic activity of macrophages, and the inhibition of platelet 
adhesion and aggregation (Suschek et al., 2004; Tuteja et al., 2004). Nitric oxide is 
formed from the guanidine-nitrogen of L-arginine by a group of isozymes termed 
nitric oxide synthases (NOS).  Although the nomenclature varies, there are three 
known NOS genes, neuronal NOS, endothelial NOS, and inducible (iNOS).  Among 
the three NOS isoforms, the neuronal and endothelial genes are constitutively 
expressed, whereas the expression of the inducible gene is dependent upon external 
factors such as exposure to pathogens.   
Nitric oxide is a gaseous molecule with a very short half-life making it 
difficult to directly measure.  However, nitric oxide production may be measured 
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indirectly by analyzing the expression of inducible nitric oxide synthase (iNOS), one 
of the enzymes responsible for the synthesis of nitric oxide.  Under normal 
physiological conditions, iNOS is not expressed by mammalian cells but rather is 
induced by exposure to proinflammatory stimuli.  In the laboratory we utilize 
lipopolysaccharide (LPS) to induce expression of iNOS and production of nitric 
oxide.  LPS is a component of the gram-negative bacterial cell wall that binds to the 
Toll-like Receptor 4 (TLR-4) and CD14 on immune cells.  Upon LPS binding to these 
receptors a signaling cascade is induced that initiates the translocation of NF-kappaB 
to the nucleus of the cell.  NF-kappaB then acts to direct the upregulation of certain 
genes to increase the transcription of iNOS as well as the proinflammatory cytokines, 
TNF-α and IL-1β.   
Immunohistochemical localization of iNOS in rats exposed to LPS shows the 
presence of the iNOS enzyme in a number of immune cells in a variety of tissues: 
macrophages, lymphocytes, neutrophils, and eosinophils within the spleen; Kupffer’s 
cells and hepatocytes within the liver; alveolar macrophages within the lung; 
macrophages in the adrenal gland; and eosinophils and mast cells within the colon 
(Bandaletova et al., 1993).  Most important for the current project, the production of 
iNOS by macrophages and other cells of the immune system provides a substantial 
degree of microbial resistance (Breitbach et al., 2006; Green et al., 1990; Hoffmann et 
al., 2006; Rossi et al., 1999; Vincendeau et al., 1992).  Mice lacking the gene for 
inducible nitric oxide synthase show an increased susceptibility to parasitic and 
bacterial infections (MacMicking et al., 1995; Murray et al., 1999; Wei et al., 1995).  
The production of large quantities of nitric oxide by macrophages also provides 
resistance to viral infections and display tumor cytotoxicity (Green & Nacy, 1993; 
Hibbs et al., 1987; Karapiah et al., 1993).  In addition to its role as an anti-microbial 
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agent, nitric oxide also serves many immunoregulatory functions.  In addition to its 
role in the control of infectious organisms, nitric oxide produced by iNOS appears to 
be involved in controlling the onset and duration of cellular immune responses (Fu & 
Blankenhorn, 1992)  For example,  there is evidence that nitric oxide suppresses the 
formation of antibodies to tetanus toxoid and sheep red blood cells following 
salmonella typhimurium immunization (Al-Ramadi et al., 1992; Eisenstein et al., 
1994).  Numerous studies have also shown an anti-proliferative effect of nitric oxide 
on lymphocytes (Albina et al., 1991).  Most importantly for the purpose of these 
studies, work in our laboratory has demonstrated that morphine alters the expression 
of nitric oxide induced by the Gram negative pathogen, Porphyromonas (Bacteroides) 
gingivalis. 
 In addition to effects on nitric oxide, there is evidence that opiate 
administration may also alter the production of the proinflammatory cytokines, TNF-
α and IL-1β (Chao et al 1993; Bencsics et al 1997; Pacifici et al 2000).  Similar to 
iNOS, IL-1β and TNF-α both play critical roles in the body’s defense against 
infectious challenge, while also serving to regulate the immune response to these 
challenges. Both IL-1β and TNF-α are proinflammatory cytokines produced primarily 
by activated macrophages.  Once secreted, IL-1β elicits widespread effects that range 
from inducing fever via actions within the hypothalamus to stimulating neutrophil 
binding along the endothelial wall to allow for infiltration to the site of an infection.  
IL-1β also stimulates T-cell activation and proliferation; B-cell maturation, 
proliferation, and immunoglobulin production, as well as the synthesis of other 
cytokines by immune cells. Interestingly, many of the proinflammatory properties of 
TNF-α resemble those of IL-1β.  In fact, these two cytokines are able to stimulate the 
production of each other, and are also capable of acting in synergy to stimulate T- and 
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B-cells.  TNF-α was initially discovered based on its ability to induce hemorrhagic 
necrosis and regression in certain tumors and has since been shown to be involved in 
a wide range of immune functions.  Among its most important functions, TNF-α 
induces fever, promotes immune cell migration to sites of infection, stimulates T- and 
B-cells to become active and proliferate, and has been shown to possess nonspecific 
antiviral properties.  In addition, it appears that both TNF-α and IL-1β are highly 
involved in LPS-induced septic shock.  Rats with LPS-induced septic shock exhibited 
a peak in TNF-α in plasma at one hour post-infection with levels beginning to decline 
by two hours after LPS administration.  Similarly, IL-1β peaked at one hour post-LPS 
and gradually returned to baseline over nine hours (Lin et al, 2006). Given the critical 
nature of these proinflammatory mediators in the initial response to infection it is 
imperative that we understand how heroin and heroin related cues may alter their 
effectiveness.       
   
Conditioned Immune Alterations 
 
 It was originally believed that the immune system functioned in isolation from 
the rest of the body and was considered to be an autonomous, self-regulating entity 
responsible for the prevention of infection and the maintenance of health.  Recently it 
has been shown that the cells and processes of the immune system are highly 
influenced by both internal and external factors that can alter the immune response 
thereby modulating the susceptibility of the host to pathogens and the progression of 
disease (e.g., Vishwanath, 1996; Straub & Besedovsky, 2003).  Factors such as an 
individual’s psychological state or learned behaviors have been shown to influence 
the functioning of the immune system.  In fact, Pavlovian conditioning of the immune 
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response is a well-documented phenomenon that can be accomplished with a wide 
variety of immunomodulatory stimuli providing some of the most concrete evidence 
for communication between the nervous and immune systems.  Research has shown 
that the pairing of a neutral stimulus that does not evoke changes in immune status 
(e.g., a sound, taste, smell or specific environment) with a stimulus that is itself 
immunomodulatory results in the formerly neutral stimulus acquiring immune altering 
properties.  Most investigators would agree that Pavlovian conditioning is an 
associative learning process by which an organism may become better prepared to 
adapt its behavior as necessary (e.g., Rescorla, 1988).  The Pavlovian conditioning of 
the immune response may be viewed as a means by which an organism learns the 
predictive value of a stimulus that has become associated with an immunologically 
relevant outcome such that it may adapt not only its behavior but the response of its 
immune system as well.  The ability of the organism to learn associations between 
stimuli predictive of immunological challenge may allow the host to alter immune 
function in anticipation of these challenges in an attempt to more adequately respond 
to environmental events.   
One of the earliest modern demonstrations of conditioned immunomodulation 
involved the pairing of the immunomodulatory drug cyclophosphamide with the 
sweet taste of saccharin.  Interestingly, Ader (1974) observed that some of the animals 
that had received pairings of CY and saccharin died when repeatedly reexposed to the 
saccharin solution alone.  Furthermore, mortality rates for these animals seemed to 
correlate with the volume of saccharin solution ingested during the conditioning trial.  
It appeared possible from these results that the taste of saccharin took on 
immunosuppressive properties of its own through its association with 
cyclophosphamide and animals exposed to the saccharin solution during testing might 
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be more susceptible to pathogens in the environment which led to increased mortality 
rates among these animals.  This was confirmed by a study in which rats underwent 
either 1- or 2- pairings of CY (50 mg/kg) with saccharin solution and three days later 
were administered an injection of the antigen, sheep red blood cells (SRBC).  
Interestingly, the experimental groups reexposed to the conditioned stimulus prior to 
testing not only demonstrated an aversion to the saccharin solution but also exhibited 
a reduction in anti-SRBC antibody titers compared to the control groups (Ader & 
Cohen, 1975).   The conditioned suppression of anti-SRBC antibodies was still 
present up to 15 days after challenge with the antigen, evidence that these effects are 
not transient but long-lasting (Ader et al., 1982; Neveu et al., 1986).  The conclusion 
reached by Ader & Cohen was that the reduction in antibodies was a result of 
“behaviourally conditioned immunosuppression” brought about by the learned 
association between the CY and the saccharin solution.  These experiments were 
replicated shortly thereafter by other laboratories who reported similar findings (e.g., 
Rogers et al., 1976; Wayner et al., 1978).  This same principle was used to show that 
conditioned immunosuppression has the ability to alter the clinical course of 
autoimmune diseases, such as systemic lupus erythematosus (Ader & Cohen, 1982; 
Olness & Ader, 1992).  Using a different immunomodulatory agent, others have 
shown a conditioned reduction in the severity of adjuvant-induced arthritis in mice 
(Lysle et al., 1992).  In addition to the conditioning of suppressive effects on immune 
function much recent research has focused on conditioned immune enhancement.   
Research has shown that exposure to a stimulus that had previously been paired with 
antigen results in an increase in antibody titers (Ader et al., 1993; Chen et al., 2004).  
Taken together, these results provided concrete evidence that conditioned 
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immunosuppression is possible and suggested that there must be a connection 
between the nervous and immune systems mediating these effects. 
The studies conducted by Ader and Cohen initially, and by others 
subsequently, have utilized similar experimental designs.  The experimental group 
receives exposure to the immunomodulatory US paired with the neutral CS either 
repeatedly or in the case of taste-immune associations only one pairing is necessary.  
At some later point, which varies between experiments, the experimental group is 
reexposed to the CS without the US and at this time may also receive an 
immunological challenge.  The specificity of the response is assured by the use of a 
comprehensive set of control groups including a non-conditioned group of animals 
that are exposed to the CS as well as the US but in a non-contingent manner.  These 
animals are subsequently reexposed to the CS during testing to confirm the lack of an 
immunological effect of the CS.  Other control groups include animals that undergo 
the conditioning paradigm but are not reexposed to the CS during testing.  This group 
serves as a control for any possible effects of the US that may still be present at the 
time of testing and for potential immunomodulatory effects of the conditioned 
procedure itself.  A group exposed to the US alone allows for the measurement of the 
unconditioned effects of the immunomodulatory agent which can then be compared to 
the conditioned effects observed in the experimental group.  Some experiments also 
include a placebo group which receives exposure to the CS but never the US.  Still 
another set of control groups may be included in which animals receive pre- or post- 
conditioning exposure to the CS which should attenuate the conditioned response and 
substantiate the effects as dependent upon associative learning processes.  The 
development and persistence of the CR is dependent on several factors and certain 
experimental manipulations may produce a weakening or inhibition of this response.   
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Two of the most widely studied experimental paradigms leading to reduced 
expression of the CR are extinction and latent inhibition.  Extinction is evident when 
after conditioning has taken place repeated exposure to the CS without the US 
decreases the CR.  Latent inhibition is a process by which repeated non-reinforced 
exposure to a stimulus prior to conditioning will inhibit the formation of a CR to that 
stimulus (Lubow & Moore, 1959).  Extinction and latent inhibition have been studied 
extensively within models of conditioning to test hypotheses concerning retroactive 
and proactive stimulus interference, respectively (Pineno & Miller, 2005).  Despite 
the wealth of literature in this area it is as yet unclear whether all immune responses 
may be conditioned and research continues to unveil the breadth and complexity of 
conditioned immunomodulation. 
 Since the early studies of Ader and Cohen, conditioning of the immune 
response has been shown in a number of different ways.  Early studies in our own 
laboratory demonstrated that a stimulus previously paired with electric shock 
treatment will induce a number of immune alterations (Lysle et al., 1988; Luecken & 
Lysle, 1992; Perez & Lysle, 1995).  In addition, conditioning to aversive stimuli such 
as electric shock was found to be mediated through opioid receptors as evidenced by 
the ability of naltrexone to block the conditioned response (Lysle et al., 1992; Perez & 
Lysle, 1997).  This led to the study of whether the immunomodulatory properties of 
exogenous opioids, such as heroin and morphine, could be conditioned to 
environmental stimuli.  Several investigators have shown that many of the 
physiological and behavioral responses to opioids may be conditioned to previously 
drug-paired stimuli.  For example, environmental stimuli that had previously been 
paired with morphine administration can elicit such morphine-like effects as 
hyperthermia when presented in the absence of morphine (Bardo & Valone, 1994; 
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Eikelboom & Stewart, 1979; Miksic et al., 1975; Schwarz & Cunningham, 1990; 
Wikler & Pescor, 1967).  Similar results have been seen with the conditioning of 
morphine’s analgesic properties such that exposure to morphine-associated stimuli 
induces a conditioned analgesic response in the absence of drug (Miller et al 1990; 
Bardo & Valone 1994).  There has been increasing evidence from studies conducted 
on human subjects showing that drug-paired stimuli can cause intense craving, 
feelings of being ‘high’, galvanic skin responses, autonomic arousal, and altered 
neural activity in drug users (Sideroff & Jarvik 1980; Ehrman et al. 1992; Foltin & 
Haney 2000).  Exposure to drug cues is one of the key contributing factors to relapse 
mainly because these cues induce a wide variety of complex, classically conditioned 
physical and behavioral responses (Unnithan et al 1992; Derbas et al 2001)..        
 In line with these studies, our laboratory provided the first evidence that 
alterations of immune status can be conditioned to environmental stimuli that have 
been paired with morphine administration (Coussons et al., 1992; 1994a; 1994b).  
More recently we have demonstrated that heroin’s effects on nitric oxide expression 
may also be conditioned to environmental stimuli.  In those investigations, rats 
received subcutaneous injections of heroin (1 mg/kg) upon placement into a distinct 
environment.  When rats were subsequently re-exposed to the environment without 
heroin administration the production of nitric oxide was suppressed similar to that 
seen with heroin administration (Lysle & Ijames, 2002).  Overall, these data suggest 
that the conditioned effects of heroin on nitric oxide involve a learned association 
between the drug and the environment in which it is delivered and that blocking the 
acquisition and/or expression of this association may prevent these effects.  Current 
research in the area of drug addiction has focused on the critical task of reducing 
relapse rates by attempting to curb cue induced drug seeking behavior, however, it is 
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also imperative to take into account the widespread effects these cues may have on 
immune functioning and the ability of previous drug users to combat infectious 
disease while in recovery.  These results are important, not only because they provide 
the first demonstration that immunologic alterations can be conditioned to drug cues 
paired with heroin administration, but also because they have profound implications for 
opioid/immune interactions.  One key implication is that the host response to opioids 
will not be static, but will change as the organism learns to predict the administration 
of the drug on the basis of distinctive stimuli in the environment.  These effects need 
to be factored into the comprehensive treatment of opiate users.   
 
Neural Substrates 
 
 Conditioning of the immune response involves the learning of an association 
between the neutral stimulus (CS, e.g., the conditioning chamber) and the 
immunomodulatory unconditioned stimulus (US, e.g., the immunomodulatory effects of 
heroin), such that the CS may take on the immunomodulatory properties of the US.  
This learned association is similar to many other forms of learning and may involve 
similar brain structures.  Several investigators have demonstrated a role of the 
basolateral amygdala (BLA) in associative learning.  For example, lesions of the BLA 
block classical eye blink conditioning (Blankenship et al., 2005), inhibit conditioned 
fear responses to aversive stimuli in rats (Lee et al.,  2005), and block acquisition of the 
motivational value of an appetitive US (Setlow et al., 2002).  In addition, learning of an 
inhibitory avoidance task involves neuronal activity within the BLA (Chang et al., 
2005)  as does olfactory fear conditioning (Sevelinges et al., 2004) and conditioning of 
odorant attractiveness in female mice (Moncho-Bogani et al., 2005). 
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       More importantly for the purposes of these studies, the BLA has been 
implicated in the control of the formation of stimulus-reward associations within 
models of drug abuse.  Conditioning to drug-related cues has become a major focus 
within the study of drug addiction and relapse.  Exposure to previously drug-paired 
stimuli will reinstate drug seeking behavior in rats who have undergone extinction 
training (Gracy et al., 2000).  However, inactivation of the BLA will block the ability of 
drug cues to reinstate drug seeking in rats that had been previously taught to self-
administer cocaine.  Interestingly, this same study did not show an effect of BLA 
inactivation on self-administration of cocaine suggesting that the BLA is critical for 
conditioned but not unconditioned reinforcement (Meil & See, 1997).  In a similar 
study, inactivation of the BLA was shown to abolish cue-induced reinstatement of drug 
seeking in rats taught to administer heroin (Fuchs & See, 2002).  Furthermore, animals 
receiving morphine injections paired with a distinct environment showed greater Fos 
activation within the BLA when exposed to that environment than animals receiving 
un-paired injections (Harris & Ashton-Jones, 2003).  Similarly, cocaine-associated 
cues elicited neural activity within the BLA nearly identical to that seen upon 
intravenous delivery of cocaine in rats taught to self-administer (Carellia et al., 2003).  
Taken together, these studies provide clear and consistent rationale supporting the 
investigation of the BLA as part of the neurobiological circuitry involved in the 
conditioned immune responses to heroin. 
 Interestingly, dopamine receptors within the BLA have been shown to play a 
role in learning and memory as well as classical conditioning.  Post-training intra-BLA 
dopamine infusions enhance memory consolidation of an inhibitory avoidance task 
(LaLumiere et al., 2004).  Additionially, Macedo et al. (2007) demonstrated that 
antagonism of dopamine D1 receptors within the BLA reduces the expression of 
 26
conditioned, but not unconditioned, fear.  Dopaminergic signaling within the BLA 
appears to be particularly important for conditioned responses to drugs of abuse.  For 
example, stimulation of dopamine D1 receptors in the BLA is necessary for the 
expression of CS-induced reinstatement of cocaine-seeking behavior in rats (See et 
al., 2001; Yun & Fields, 2003).  Similarly, intra-BLA administration of D-
amphetamine potentiates cue-induced cocaine seeking possibly by increasing 
monoamine tone.  In contrast, D2 receptors in the BLA appear to be involved in the 
acquisition of CS-US associations that guide subsequent CS-induced cocaine-seeking 
behavior (Berglind et al., 2006).  These findings provide a strong rationale for 
examining the involvement of dopamine D1 and D2 receptors in the BLA on the 
acquisition and expression of heroin-conditioned immunomodulation. 
   
Goals of the Dissertation 
 This dissertation aims to further current knowledge regarding opioid-induced 
immunomodulation, specifically by filling a void in our understanding of the neural 
circuitry mediating the effects of drug cues on immune processes.  Published 
preliminary data (Lysle & Ijames, 2002) indicate that heroin-induced alterations in 
nitric oxide production may be conditioned to environmental stimluli that predict drug 
availability  The experiments presented herein extend these finding by elucidating 
neural mechanisms whereby drug cues may alter the expression and production of 
certain proinflammatory mediators essential for host defense.  The experiments in 
Chapter 2 demonstrate that the conditioned alterations in nitric oxide production 
induced by exposure to previously heroin-paired stimuli are a true form of associative 
learning as the conditioned response is susceptible to both extinction and latent 
inhibition.  Chapter 3 reveals that the basolateral amygdala (BLA), an area of the 
brain which has been implicated in the formation of stimulus-reward associations 
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within models of drug abuse, is necessary for the expression of the conditioned 
response.  Administration of a combination of the GABA agonists, muscimol and 
baclofen, directly into the BLA blocked the conditioned suppression of 
proinflammatory mediators while administration of these same drugs into an adjacent 
region of the caudate did not alter the response.  The experiments outline in Chapter 
4 show that the pharmacological blockade of dopamine, D1 receptors in the BLA 
reverses the conditioned suppression induced by exposure to previously heroin-paired 
stimuli.  The administration of the dopamine D1 antagonist, SCH23390, but not the D2 
antagonist, raclopride, resulted in attenuation of the conditioned effect.  These studies 
are important because they are the first to investigate the neural circuitry involved in 
the conditioned immune alterations produced by exposure to drug cues.  Overall, 
these findings indicate a need to consider the implications of exposure to drug cues on 
the immune functioning of current and recovering heroin users.
  
 
 
 
CHAPTER 2 
 
CONDITIONED EFFECTS OF HEROIN ON NITRIC OXIDE EXPRESSION ARE 
SUSCEPTIBLE TO EXTINCTION AND LATENT INHIBITION 
 
 
Introduction 
The high prevalence of opportunistic infections among heroin users has long 
suggested that heroin use may alter resistance to infectious disease (Luttgens 1949; 
Hussey and Katz 1950; Louria et al. 1967; Garten et al. 2004). Although there has 
been speculation that this high rate of infection may be due to non-sterile intravenous 
administration of drug, there is increasing evidence suggesting that opiates directly 
alter immune status (Brown et al. 1974; McDonough et al. 1980; Nair et al. 1986; 
Donahoe et al. 1986; Novick et al. 1989; Oschorn et al. 1990; Govitrapong et al. 
1998; Sharp et al. 2001). Studies in our laboratory have shown that heroin induces 
alterations in a number of immunological parameters including alterations in natural 
killer cell activity, T- and B-lymphocyte proliferation, and nitric oxide production 
(Fecho et al. 2000; Lysle and How 2000). The reduction in nitric oxide production 
induced by heroin administration is dose-dependent and appears to be mediated 
through opioid receptors, as these alterations are reversed upon administration of the 
opioid antagonist, naltrexone (Lysle and How 2000). The production of nitric oxide 
by immune cells, particularly macrophages, provides a substantial degree of microbial 
resistance (Green et al. 1990; Nathan and Hibbs 1991; Vincendeau et al. 1992; Rossi 
et al. 1999). Mice lacking the gene for inducible nitric oxide synthase show an 
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increased susceptibility to parasitic and bacterial infections (MacMicking et al. 1995; 
Wei et al. 1995; Lindgren et al. 2004). The production of large quantities of nitric 
oxide by macrophages also provides resistance to viral infections and displays tumor 
cytotoxicity (Karupiah et al. 1993; Chang et al. 2003; Hrabak et al. 2006). In addition 
to its role as an anti-microbial agent, nitric oxide also serves many immunoregulatory 
functions. There is evidence that nitric oxide suppresses the formation of antibodies to 
tetanus toxoid and sheep red blood cells after Salmonella typhimurium immunization 
(Al-Ramadi et al. 1992; Eisenstein et al. 1994). Numerous studies have also shown an 
anti-proliferative effect of nitric oxide on lymphocytes (Albina and Henry 1991). 
Thus, nitric oxide plays a critical role in immune processes and may be involved in 
the altered susceptibility to infection evident in heroin users.  
Although it is now apparent that heroin impairs immune status, there has been 
limited research on how conditioned drug cues may also induce changes in immune 
function.  Classical or Pavlovian conditioning is a well-characterized learning 
phenomenon in which a formerly neutral stimulus (the conditioned stimulus [CS], 
such as the conditioning chamber) will begin to elicit a response (the conditioned 
response [CR]) after repeated pairing with a biologically relevant stimulus (the 
unconditioned stimulus [US], such as heroin) that had elicited a response upon its first 
presentation (Pavlov, 1927).  Several investigators have shown that many of the 
physiological and behavioral responses to drugs of abuse may be conditioned to 
previously drug-paired stimuli.  In line with these studies, our laboratory has recently 
provided new data indicating that heroin’s effects on nitric oxide expression may be 
conditioned to environmental stimuli.  In those investigations, rats received 
subcutaneous injections of heroin (1 mg/kg) upon placement into a distinctive 
environment which served as the CS.  When rats were subsequently re-exposed to the 
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environment without further heroin administration the production of nitric oxide was 
suppressed similar to that seen with heroin administration (Lysle & Ijames, 2002).  
These data provided the first evidence that heroin-induced alterations in nitric oxide 
expression may be conditioned to environmental stimuli. 
The development and persistence of the CR is dependent on several factors 
and certain experimental manipulations may produce a weakening or inhibition of this 
response.   Two of the most widely studied experimental paradigms leading to 
reduced expression of the CR are extinction and latent inhibition.  Extinction is 
evident when after conditioning has taken place repeated exposure to the CS without 
the US decreases the CR.  Latent inhibition is a process by which repeated non-
reinforced exposure to a stimulus prior to conditioning will inhibit the formation of a 
CR to that stimulus (Lubow & Moore, 1959).  Extinction and latent inhibition have 
been studied extensively within models of conditioning to test hypotheses concerning 
retroactive and proactive stimulus interference, respectively (Pineno & Miller, 2005).  
The susceptibility of conditioned heroin-induced immune alterations to the effects of 
extinction and latent inhibition demonstrate that this conditioning paradigm is a true 
form of associative learning and adheres to accepted principles of learning.  
Furthermore, given the important health consequences that may result from 
conditioned immune alterations the assessment will identify procedures that influence 
the CR.   
Given this information, it was hypothesized that both pre- and post-exposure 
to the drug-paired environment (i.e., the CS) should reduce the conditioned effects of 
heroin on nitric oxide production.  To test this hypothesis, the present study evaluated 
the effects of two behavioral manipulations, pre- and post-exposure to the CS, on the 
conditioned suppression of iNOS.  Rats received five training sessions in which 
 31
heroin was administered immediately upon placement into a standard conditioning 
chamber which served as the CS.  In the first experiment, the experimental group 
[Extinction(Ext)] was exposed to the conditioning chamber without drug for 60-min 
on each of ten consecutive days following the final conditioning session to induce 
extinction.  In the second experiment, the experimental group [Latent Inhibition (LI)] 
received ten consecutive days of 60-min non-reinforced pre-exposure to the chamber 
to induce latent inhibition.  Three control groups were included to ensure that the 
observed results were due to the behavioral manipulations employed.  An additional 
unmanipulated comparison group was included in which the animals received no 
exposure to the conditioning chambers and no drug treatment.  On the test day, the 
animals were re-exposed to the chamber for 60-min without drug administration and 
given a subcutaneous injection of LPS (1000 µg/kg) upon removal.  Previous research 
in our laboratory has shown that heroin induces a dose dependent reduction in LPS-
induced iNOS mRNA expression in the spleen, lung, and liver.  The findings reported 
here are important because they indicate that previously heroin-associated 
environmental stimuli are not only capable of inducing alterations in nitric oxide 
expression but that these effects may be modified by manipulations of the relationship 
between the environment and drug delivery.  These results further implicate a role for 
associative learning processes in the conditioned effects of heroin on nitric oxide and 
suggest that these effects may be mediated, at least in part, by centrally located neural 
substrates of learning.     
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Materials and Methods 
Animals 
Male Lewis rats, weighing 225-250 g, were purchased from Charles River 
Laboratories (Raleigh, N.C., USA).  Upon arrival, animals were housed individually 
in plastic cages in a colony room with a reversed light-dark (12h) cycle maintained 
through artificial illumination.  The animals were allowed access to food and water ad 
libitum throughout the experiment.  All animals were given a 2-week habituation 
period before the start of experimental manipulations and were handled regularly 
during this time.  All procedures described were approved by the IACUC of the 
University of North Carolina at Chapel Hill and conformed to National Institutes of 
Health (NIH) Guidelines on the Care and Use of Laboratory Animals. 
Drug Administration 
Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD) and dissolved in 
0.9% sterile saline.  Animals received a subcutaneous injection of heroin at 1 mg/kg 
immediately before placement in the conditioning chamber on each of the five 
conditioning trial days.  This dose was selected based on prior experiments in our 
laboratory showing that a 1 mg/kg dose of heroin alters LPS-induced iNOS mRNA 
expression and induces conditioning (Lysle and How 2000; Lysle and Ijames 2002). 
A subsequent study used 3.0 or 0.3 mg/kg heroin doses. The 0.3 and 3.0 mg/kg doses 
were included to investigate the effect of altering the dose of heroin administered 
during conditioning on the expression of extinction and latent inhibition. This study 
also included a control group that was injected with saline-vehicle during 
conditioning. 
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Conditioning Procedures 
To condition heroin’s effects on iNOS expression, all animals received five 60-min 
training sessions in which they received a subcutaneous injection of heroin upon 
placement into a standard conditioning chamber. Training sessions were separated by 
48 h. The conditioning chambers (BRS/LVE, Laurel, MD, USA) were contained in a 
room separate from the animal colony and contained a metal grid floor design and 
cedar bedding to create an environment distinct from that of the home cage. All 
conditioning took place during the dark phase of the light cycle, and the conditioning 
chambers were kept dark. The test day took place 10 days after the final conditioning 
session. Animals were placed back into the conditioning chambers without 
administration of heroin. After 60 min, the animals were removed from the chambers 
and given a subcutaneous injection of LPS (1,000 µg/kg) to induce iNOS production. 
Six hours after LPS administration, all animals were killed, and samples of spleen, 
liver, and blood were collected for analysis. The 6-h time point was selected based on 
previous research in our laboratory showing maximal iNOS induction at 6 h after LPS 
administration (Lysle and How 2000). 
Extinction 
This study tests whether post-conditioning exposure to a heroin-paired environment 
without further drug administration would attenuate the conditioned effects of heroin 
on nitric oxide production. In this experiment, rats were assigned to one of five 
groups. A schematic representation of these treatment groups is shown in Table 2.1. 
Four of the groups underwent conditioning, during which, rats received an injection of 
heroin (1 mg/kg) upon placement into the conditioning chamber. Two of the 
conditioned groups [extinction (Ext) and extinction/control (Ext/Ctl)] were then 
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subjected to the extinction procedure, whereas the other two groups remained in their 
home cages [conditioned (Cond) and conditioned/control (Cond/Ctl)]. The extinction 
procedure consisted of ten consecutive days of exposure to the conditioning chambers 
for 1 h a day without administration of heroin. The test day took place on the day after 
the completion of the extinction procedure just described. On the test day, two groups 
[one group that had received extinction (Ext) and one group that had not (Cond)] were 
re-exposed to the conditioning chambers (i.e., the conditioned stimulus [CS]), 
whereas the other groups remained in their home cages. Re-exposed animals were 
placed in the chambers for 1 h without heroin and received an injection of LPS 
(1,000 µg/kg) upon removal. All remaining animals also received an LPS injection at 
this time. Extinction control (Ext/Ctl) and conditioning control (Cond/Ctl) groups 
were used to control for any ancillary effects of the extinction and conditioning 
procedures, respectively. These groups underwent the conditioning protocol but were 
not re-exposed to the chamber on test day. The fifth group (HC) received no 
conditioning and remained in the home cage throughout the duration of the 
experiment, serving as a general control.  
_____________________________________________________________________ 
 
Table 2.1 Treatment groups: Extinction and Latent Inhibition Experiments 
_____________________________________________________________________ 
Extinction:  Days 1-9  Days 10-20  Test Day 
HC         LPS 
Cond    Conditioning     CS/LPS 
Ext    Conditioning  Extinction  CS/LPS 
Ext/Ctl   Conditioning  Extinction  LPS  
Cond/Ctl   Conditioning     LPS 
Latent Inhibition: Days 1-10  Days 11-19  Test Day 
HC         LPS 
Cond      Conditioning  CS/LPS 
LI   Pre-Exposure  Conditioning  CS/LPS 
LI/Ctl   Pre-Exposure  Conditioning  LPS 
Cond/Ctl     Conditionoing  LPS 
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Latent Inhibition 
This study tests whether pre-exposure to the conditioning chamber would create a 
latent inhibition of the conditioned effects of heroin on iNOS expression. As with the 
previous experiment, rats in this experiment were assigned to one of five groups. A 
schematic representation of the treatment groups is shown in Table 2.1. Four of the 
groups underwent conditioning, during which, rats received an injection of heroin 
(1 mg/kg) upon placement into the conditioning chamber. Two of the groups that 
would receive conditioning [latent inhibition (LI) and latent inhibition/control 
(LI/Ctl)] underwent the latent inhibition procedure before the start of conditioning, 
whereas the other two groups remained in the home cages. The latent inhibition 
procedure consisted of ten consecutive days of exposure to the conditioning chambers 
before the first conditioning session. These pre-exposures lasted for 1 hour, and no 
drug was given at this time. On the day after the final pre-exposure, the rats were 
subjected to the conditioning procedures described above. On the test day, two groups 
[one that had undergone pre-exposure (LI) and one group that had not (Cond)] were 
re-exposed to the conditioning chambers, whereas the other animals remained in the 
home cage. Re-exposed animals received an injection of LPS (1,000 µg/kg) upon 
removal from the chambers. All remaining animals also received an LPS injection at 
this time. Latent inhibition control (LI/Ctl) and conditioning control (Cond/Ctl) 
groups were used to control for any ancillary effects of the pre-exposure and 
conditioning procedures, respectively. These groups underwent the conditioning 
protocol, but were not re-exposed to the chamber on test day. A fifth group (HC) 
received no conditioning and remained in the home cage throughout the duration of 
the experiment, serving as a general control.    
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Dose Dependency 
In this set of experiments, we sought to determine the effects that altering the dose of 
heroin given during conditioning might have on the expression of extinction or latent 
inhibition. During the conditioning phase of the experiment, animals received five 
sessions in which an injection of 0, 0.3, or 3.0 mg/kg heroin was given upon 
placement into the conditioning chambers. For each experiment, rats were assigned to 
one of six groups. For the extinction experiment, one group of rats from each of the 
three conditioning doses of heroin was subjected to the extinction procedure. After the 
last conditioning session, the extinction groups were given ten consecutive days of 1 h 
exposures to the conditioning chambers. For the latent inhibition experiment, one 
group of rats from each of the three conditioning doses of heroin was subjected to the 
latent inhibition procedure. For ten consecutive days before the first conditioning 
session, the latent inhibition groups were pre-exposed to the conditioning chambers 
for 1 h each day. There was no drug given during the extinction or the latent 
inhibition sessions. On test day, all animals were re-exposed to the conditioning 
chambers. Upon removal from the chambers, all animals received an injection of LPS 
(1,000 µg/kg).  
Real Time RT-PCR  
To determine iNOS expression, real time RT-PCR was performed on tissue samples 
from the spleen and liver.  Total RNA was extracted from a section of each of the 
tissues using TRI-Reagent (Molecular Research Center, Cincinnati, OH), a 
modification of the original method described by Chomczynski and Sacchi (1987).  
RNA was quantified spectrophotometrically (GeneQuant II, Pharmacia-Biotech, 
Piscataway, NJ, USA).  For the RT-PCR, reverse transcription is performed using 
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Oligo(dT)18 primer and Moloney Murine Leukemia Virus-Reverse transcriptase 
following the protocol of the Advantage RT-for-PCR Kit from Clontech (Palo Alto, 
CA, USA).   
PCR amplifications were performed using the Fast StartTM DNA Master SYBR 
Green I Real-Time PCR Kit (Roche) and the LightCycler instrument (Roche).  A 
master mix containing all reaction components was prepared for all reactions, with 
each reaction using a 20 ml mix placed in glass capillary tubes specifically designed 
for use in the LightCycler system.  The PCR primer set for iNOS, 5’-
CCCTTCCGAAGTTTCTGGCAGCAGC-3’ and 5’-GGGTGTCAGA-
GTCTTGTGCCTTTGG-3’ was synthesized by the Nucleic Acids Core Facility 
(Lineberger Cancer Center, UNC-Chapel Hill).  Copy numbers were generated from 
an external standard curve.  Amplifications were carried out for 40 cycles and curves 
showing fluorescence at each cycle were determined by the computer software 
(Roche).  Samples were pre-incubated for 10 minutes at 95o C to activate the Fast-
Start Taq DNA polymerase.  The cycle temperatures were 95, 60, and 72oC for the 
denaturing, annealing, and extending, respectively.  The cycle times were 15, 5, and 
25 s for the denaturing, annealing, and extending, respectively.  Flourescence level 
was determined at the end of the extending phase for each cycle of PCR.  The analysis 
of the fluorescence level in standards and samples over the course of 40 cycles was 
used to derive the number of copies of the target molecule in each sample.  
Additionally, assessments of housekeeping gene expression, cyclophilin, were made 
to assure comparable quality of RNA among samples.  The sequence of the 
cyclophilin primers was 5’-CCAAGACTGAGTGGCT-3’ and 5’-
AGATTACAGGGTATTGCG-3’.  The data are expressed as a copy number of iNOS 
(per 10ng cDNA) based on the standard curve using the Lightcycler software (Roche).   
 38
Furthermore, to confirm the nature of amplification product, a melt curve 
analysis was conducted after the final PCR cycle.  This analysis involved denaturing 
the products by slowly heating them to 95oC, during which fluorescence is 
continuously measured.   
Nitrite/Nitrate Assay 
The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent 
assay.  Nitrate and nitrite are formed non-enzymatically when nitric oxide is exposed 
to oxygen, thus plasma levels of these products indicate the level of nitric oxide 
production.  Total nitrite/nitrate levels is determined by the conversion of nitrate to 
nitrite utilizing nitrate reductase in the presence of NADPH and flavin adenine 
dinucleotide, and then an assessment using Greiss reagent.  Briefly, 6 µl of plasma 
diluted in 44 µl of dH2O is incubated for in the dark for 90-min with 10 µl of nitrate 
reductase (1.0 unit/ml), 20 µl of a 0.31 M phosphate buffer (ph 7.5), 10 µl of 0.86 
mM NADPH (Sigma), and 10 µl of a 0.11 mM flavin adenine dinucleotide in 
individual wells of a 96-well plate.  Then, 200 ml of Griess reagent consisting of a 1:1 
(v/v) solution 1% sulfanilamide in 5.0% phosphoric acid and 0.1% N-(1-
napthyl)ethyl-enedamine dihydrochloride in distilled water was added to the samples.  
The color developed for ten minutes at room temperature after which the absorbance 
was determined using a spectrophotometer set at 550 nm.  All reactions were carried 
out in triplicate.  The total micromolar concentration of nitrite is determined for each 
sample based on a standard curve.  Recovery of nitrate is greater than 95% using this 
assay. 
 
 39
Statistical Analysis 
The data from the initial extinction and latent inhibition studies were analyzed by one-
way analysis of variance (ANOVA) followed by planned comparisons to compare all 
groups to the unmanipulated control. The data from the heroin dose studies were 
analyzed by two-way ANOVA, with the first factor set as pre- or post- exposure and 
the second factor as dose. For the extinction experiment, planned comparisons of the 
extinction group to the conditioned group were conducted at each of the three heroin 
doses. For the latent inhibition experiment, planned comparisons of the latent 
inhibition group to the conditioned group were conducted at each of the three heroin 
doses. All analyses were conducted with the level of significance set at p<0.05.  
 
Results 
Extinction 
 The first set of experiments examined whether repeated post-conditioning 
exposure to the previously drug-paired environment (i.e., the conditioned stimulus 
[CS]) would alter the conditioned effects of heroin on nitric oxide production.  Figure 
2.1 shows the effects of the extinction procedure on LPS-induced expression of iNOS 
mRNA in spleen and liver tissue.   
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Figure 2.1: The extinction procedure attenuates heroin-induced conditioned suppression 
of LPS-induced expression of iNOS mRNA in the spleen and liver as determined by 
real-time RT-PCR.  The data are expressed as iNOS copy number per 10 ng cDNA 
based on a standard curve using Roche LightCycler software.  The error bars 
represent the standard error of the mean. 
 
Analysis of iNOS copy number in spleen and liver revealed a significant main effect 
of treatment [F(4,15)=3.60, P<0.05; F(4,15)=6.96, P<0.01].  Moreover, the group that 
underwent conditioning and was re-exposed to the conditioning chamber on test day 
(Cond) exhibited a significant reduction in iNOS mRNA as compared to the home 
cage control (HC) group.  This significant difference was evident in both spleen and 
liver tissue (P<0.05) which supports our earlier findings indicating that exposure to a 
previously heroin-paired environment reduces the expression of iNOS mRNA.  Most 
importantly, there were no significant differences between the HC group and the 
extinction (Ext) group demonstrating that repeated exposure to the drug-paired 
environment after conditioning attenuates the conditioned response.  Furthermore, 
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there were no significant differences between the HC group and any of the control 
groups indicating that these results are specific to the behavioral manipulations and 
are not due to ancillary effects of the conditioning or extinction procedures.  As 
shown in Table 2.2, there were also no differences found in expression of the 
housekeeping gene, cyclophilin, between any of the groups indicating that the 
alterations in mRNA were specific for iNOS and not the result of an overall reduction 
in RNA expression or production.   
 
Table 2.2  
Cyclophilin copy numbers in the spleen and liver as determined by real time RT-PCR 
Extinction 
Group:   Spleen    Liver_____________ 
HC                  515849(±172651)  110982(±30772) 
Cond       539189(±140745)  103034 (±19144) 
Ext        586327 (±74685)   152554 (±25171) 
Ext/Ctl       553067 (±106493)  101224 (±27674) 
Cond/Ctl       724616 (±126050)   109251 (±37130 
 
The data are expressed as mean cyclophilin copy number (±SEM) per 10 ng cDNA 
sample based on a standard curve using Roche LightCycler software.  No differences 
between treatment groups. 
 
 The data in Fig. 2.2 show the effects of each procedure on serum nitrite/nitrate 
levels. The ANOVA revealed a significant main effect of procedure [F(4,15) = 7.83, 
P<0.01] on the levels of nitrite/nitrate in the serum. Planned comparisons showed a 
significant difference between the HC group and the Cond group [F(1,15) = 24.21, 
P<0.001), further supporting our earlier findings that exposure to a previously heroin-
paired environment lowers the levels of nitrite/nitrate in the serum, indicating a 
reduction in nitric oxide production. There were no significant differences between 
the HC group and the Ext group indicating that the extinction procedure attenuated 
the conditioned response. There were also no differences between the HC group and 
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any of the control groups indicating that the results are specific to the extinction and 
conditioning procedures. The levels of serum nitrate reported here may result from a 
variety of sources the individual contributions of which are not distinguished. 
Whereas iNOS is one source of serum nitrate, there are several other factors that may 
contribute, including endothelial nitric oxide synthase and dietary sources. The data 
presented below represent an overall alteration in nitric oxide production. 
 
 
 
Figure 2.2: The extinction procedure attenuates heroin-induced conditioned 
suppression of LPS-induced expression of serum nitrate levels as determined by the 
Greiss Reagant Assay.  The data are expressed as the mean micromolar concentration 
of nitrite/nitrate. The error bars represent the standard error of the mean. 
 
Latent Inhibition 
 
    To test whether a latent inhibition of the conditioned effects of heroin of iNOS 
could be induced, rats were given exposure to the conditioning chambers before the 
start of conditioning.  Figure 2.3 shows the effects of the latent inhibition procedure 
on LPS-induced iNOS expression in the spleen and liver.  Analysis revealed an 
overall effect of  
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Figure 2.3  Effect of latent inhibition procedure on LPS-induced expression of iNOS 
mRNA in the spleen and liver as determined by real-time RT-PCR. The data are 
expressed as the mean iNOS copy number per 10 ng cDNA sample based on a 
standard curve using Roche LightCycler software. The error bars represent the 
standard error of the mean. 
 
 
treatment on iNOS copy numbers in the spleen and liver [F(4,15)=3.73, P<0.05; 
F(4,15)=3.65, P<0.05]. Planned comparisons showed a significant reduction in iNOS 
levels in both spleen and liver tissue in the Cond group as compared to the HC group 
[F(1,15) = 13.91, P<0.005; F(1,15) = 16.0, P<0.01).  Again, these findings are in line 
with our earlier reports indicating that exposure to a previously heroin-paired 
environment will reduce the expression of iNOS mRNA.  There are no significant 
differences between the HC group and the latent inhibition (LI) group indicating that 
pre-exposure to the drug-paired environment was able to reduce the conditioned 
effects of heroin on iNOS production.  Furthermore, there were no differences 
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between the HC group and any of the control groups.  To ensure that these alterations 
were specific to iNOS mRNA production and not the result of an overall reduction in 
RNA processing, real-time RT-PCR was performed on the housekeeping gene, 
cyclophilin.  There were no significant differences between any of the experimental 
groups in cyclophilin mRNA copy numbers.  Table 2.3 shows that there was no effect 
of group on cyclophilin mRNA copy numbers. 
 
Table 2.3  
Cyclophilin copy numbers in the spleen and liver as determined by real time RT-PCR 
Latent Inhibition 
Group:   Spleen    Liver_____________ 
HC                  756161(±138641)  128400(±23453) 
Cond       755821(±110264)  178192 (±46869) 
Ext        826480 (±70957)   175650 (±37319) 
Ext/Ctl       658687 (±191141)  163542 (±27482) 
Cond/Ctl       781717 (±144229)   161625 (±16680) 
 
 
Figure 2.4 shows the effects of the latent inhibition procedure on the concentration of 
nitrite/nitrate in the serum.  Analysis revealed a main effect of procedure on 
nitrite/nitrate levels [F(4,19)=3.63, P<0.05].  In line with our previous experiments, 
the Cond group exhibited significantly lower levels of serum nitrite/nitrate than the 
HC group [F(1,15) = 41.09, P<0.001)].  There were no significant differences 
between the HC group and the LI group, again demonstrating that pre-exposure was 
able to attenuate the conditioned response.  There were also no differences found 
between the HC group and any of the control groups.   
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Figure 2.4  Effect of latent inhibition procedure on serum nitrite/nitrate levels as 
determined by the Greiss reagent assay. The data are expressed as the mean 
micromolar concentration of nitrite/nitrate. The error bars represent the standard error 
of the mean. 
 
Effect of Dose 
In the following set of experiments, we sought to determine the effects that altering 
the dose of heroin given during conditioning might have on the expression of 
extinction or latent inhibition. Figure 2.5 shows the effects of heroin conditioning 
dose on the expression of extinction. The analysis of iNOS copy number revealed a 
significant main effect of extinction in both the spleen and the liver, respectively 
[F(1,18) = 14.7, P<0.01; F(1,18) = 5.08, P<0.05)]. There was also a significant dose 
by extinction interaction within the spleen [F(2,18) = 8.72, P<0.005]. Planned 
comparisons revealed that both the 3 mg/kg conditioned and the 0.3 mg/kg 
conditioned groups showed significantly lower iNOS copy numbers in the spleen 
[F(1,18) = 15.29, P<0.005; F(1,18) = 15.37, P<0.005)] and liver [F(1,18) = 5.15, 
P<0.05; F(1,18) = 5.06, P<0.05)] when compared to the extinction group at the same 
dose. These data indicate that the extinction procedure was able to block the 
conditioned suppression of iNOS in both the spleen and liver when either 0.3 or 
3.0 mg/kg of heroin was used during the conditioning phase of the experiment.  
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Figure 2.5  Effect of extinction and dose on LPS-induced expression of iNOS mRNA 
in the spleen and liver as determined by real-time RT-PCR. The data are expressed as 
the mean iNOS copy number per 10 ng cDNA sample based on a standard curve 
using Roche LightCycler software. The error bars represent the standard error of the 
mean. 
 
 
Figure  2.6 shows the effect of heroin conditioning dose on the extinction of LPS-
induced nitrite/nitrate production. The assay revealed a significant main effect of 
extinction [F(1,18) = 22.38, P<0.001] on nitrite/nitrate levels in the blood and a dose 
by extinction interaction [F(2,18) = 7.72, P<0.01]. Moreover, there was a significant 
reduction in nitrite/nitrate levels in both the 3 and 0.3 mg/kg conditioned groups as 
compared to the extinction groups conditioned at the same heroin dose [F(1,18) = 
22.09, P<0.0005; F(1,18) = 14.59, P<0.005]. Thus, the conditioned alteration in iNOS 
was attenuated by the extinction procedure at both the high and low heroin doses. 
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Figure 2.6  Effect of extinction and dose on serum nitrite/nitrate levels as determined 
by the Greiss reagent assay. The data are expressed as the mean micromolar 
concentration of nitrite/nitrate. The error bars represent the standard error of the mean. 
 
 
Figure 2.7 shows the effects of heroin dose on the susceptibility of conditioned 
immunomodulation to latent inhibition. The analysis of iNOS copy number revealed a 
significant main effect of dose in the spleen and liver, respectively [F(2,18) = 11.38, 
P<0.01; F(2,18) = 11.12, P<0.01]. Moreover, the 0.3 mg/kg conditioned group 
showed significantly lower iNOS copy numbers in the spleen [F(1,18) = 7.34, 
P<0.05] and liver [F(1,18) = 7.18, P<0.05] when compared to the 0.3 mg/kg latent 
inhibition group. The groups treated with 3 mg/kg showed suppressed iNOS levels 
compared to the saline control groups in both the spleen and liver, respectively 
[F(1,18) = 20.07, P<0.001; F(1,18) = 19.65, P<0.001]. These data show that the latent 
inhibition procedure attenuated the conditioned suppression of iNOS only at the 0.3-
mg/kg dose of heroin. 
 48
 
Figure 2.7  Effect of latent inhibition procedure and dose on LPS-induced expression 
of iNOS mRNA in the spleen and liver as determined by real-time RT-PCR. The data 
are expressed as the mean iNOS copy number per 10 ng cDNA sample based on a 
standard curve using Roche LightCycler software. The error bars represent the 
standard error of the mean. 
 
 
 The data in Figure 2.8 show the effect of heroin conditioning dose on the 
induction of latent inhibition of LPS-induced nitrite/nitrate production. The assay 
revealed a significant main effect of dose, a main effect of latent inhibition, and a 
dose by latent inhibition interaction, respectively [F(2,18) = 7.23, P<0.001; F(1,18) = 
8.1, P<0.05; F(2,18) = 7.86, P<0.005]. Moreover, there was a significant reduction in 
nitrite/nitrate levels in the 0.3 mg/kg conditioned group as compared to the 0.3 mg/kg 
extinction group [F(1,18) = 22.47, P<0.001]. In addition, the 3.0 mg/kg groups 
showed reduced nitrite/nitrate levels as compared to the saline control groups [F(1,18) 
= 14.44, P<0.005). These data reveal that the conditioned suppression of nitric oxide 
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production was attenuated by the extinction procedure only at the 0.3-mg/kg heroin 
dose. 
 
Figure 2.8  Effect of latent inhibition procedure and dose on serum nitrite/nitrate 
levels as determined by the Greiss reagent assay. The data are expressed as the mean 
micromolar concentration of nitrite/nitrate. The error bars represent the standard error 
of the mean. 
 
 
Discussion 
The results presented here provide the first evidence that exposure to a drug-
paired environment, either before or after conditioning, can reduce or even eliminate 
the conditioned effects of heroin on nitric oxide induction.  This effect appears to be 
widespread as it is found in both spleen and liver tissue as well as serum levels of 
nitrite/nitrate.  The use of several control groups further demonstrates that these 
results are specific to the manipulations and not related to ancillary effects of the 
conditioning procedures.  These results are important because they provide the first 
evidence that the conditioned effects of heroin on nitric oxide induction follow 
accepted principles of learning as they are susceptible to both extinction and latent 
inhibition.  These findings are consistent with prior investigations showing that 
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heroin-induced alterations in immune status may be conditioned to drug-paired 
stimuli (Lysle & Ijames, 2002).  In this investigation, animals received subcutaneous 
injections of heroin upon placement in a distinctive environment.  Upon re-exposure 
to that environment in the absence of drug the subjects exhibited a reduction in nitric 
oxide production similar to what is observed with actual heroin treatment.  In a 
similar study, animals administered cocaine were found to exhibit decreased 
splenocyte proliferation, reduced spleen weights and an inhibition of IL-10 production 
and these same immune alterations were evident following drug-free exposure to 
previously cocaine-paired stimuli (Kubera et al., 2008).   
The present study is consistent with these results and reconfirmed the ability of 
environmental cues to induce heroin-like alterations in immune parameters.  
Furthermore, these we were able to demonstrate that manipulations involving the 
animal’s experience with the conditioned stimulus will alter the conditioned effects of 
heroin on iNOS production.  In these experiments, animals repeatedly received 
injections of heroin (1 mg/kg) immediately upon placement into the conditioning 
chamber.  As expected, placement into the chamber without further drug 
administration was able to elicit reduction in LPS-induced nitric oxide production 
similar to that seen upon actual heroin administration.  Furthermore, both pre- and 
post-conditioning exposure to the conditioned stimulus (i.e., conditioning chamber) 
significantly reduced the conditioned response.  In order to determine the effects of 
heroin dose on the susceptiblity of the conditioned response to extinction and/or latent 
inhibition a second set of studies was conducted in which the dose of heroin given 
during conditioning trials was varied.  In the extinction dose experiments, the 
extinction procedure was able to attenuate the conditioned reduction in iNOS in both 
the 3.0 and 0.3 mg/kg heroin groups. However, the latent inhibition procedure was 
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only able to lessen the reduction in the 0.3 mg/kg group. This suggests that the high 
dose of heroin may overpower the pre-exposure parameters used in this experiment by 
providing a more salient stimulus. It is possible that extending the number of days on 
which animals receive pre-exposure may overcome the potency of the higher dose 
heroin stimulus. 
 It is well documented in the literature that a drug-paired environment or 
stimulus may elicit a response similar to that observed upon drug administration.   
Repeated pairing of drugs that activate reward pathways with environmental stimuli 
may lead to these stimuli acquiring secondary reinforcing properties and eliciting 
drug-like responses.  For example, drug-paired stimuli has been shown to cause 
intense craving, feelings of being ‘high’, galvanic skin responses, autonomic arousal, 
and altered neural activity in drug users (Sideroff & Jarvik 1980; Ehrman et al. 1992; 
Foltin & Haney 2000).  Evidence provided in the current study suggests that exposure 
to drug-paired stimuli may not only contribute to relapse, but that it may also alter the 
ability of the subject’s immune system to deal with infection.  Conditioning of the 
immune response is a well-documented phenomenon and can be accomplished with a 
wide variety of immunomodulatory stimuli, including drugs of abuse such as heroin.  
Considering the increased susceptibility to infection that occurs with opioid use it is 
possible that the conditioned alterations in certain immune parameters that occur in 
response to exposure to drug-paired cues might also compromise immune function 
and increase susceptibility to disease in recovering addicts.   
 There is evidence from both human and animal studies indicating that repeated 
exposure to drug cues without further drug use (i.e. extinction) decreases cue-induced 
conditioned responses and may therefore reduce drug seeking and craving (Childress 
et al. 1986; Calcagnetti & Schechter, 1993).  Given the number of animal studies 
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showing decreased drug seeking following extinction this study sought to determine if 
it would be possible to reduce the conditioned immune response to a drug-paired 
environment by manipulating the animal’s exposure to the conditioned cues.  The data 
presented here indicate that both extinction and latent inhibition procedures attenuate 
heroin’s conditioned effect on iNOS production.  In the extinction experiment, rats 
that were repeatedly placed in the formerly drug-paired environment without drug 
administration did not exhibit a reduction in iNOS production when re-exposed to this 
environment, unlike those animals that had not undergone extinction.  Some studies 
have shown that whereas extinction may reduce the occurrence of conditioned drug-
like responses in a controlled environment such as the laboratory, these treatments 
may have little to no effect on rehabilitation (Dawe et al. 1993; Niaura et al. 1999). 
This may be due to several factors, including the ability of these cues to be easily 
reconditioned and the complexity of the cues themselves. Whereas the nature of the 
CS may be controlled in an experimental setting, there is no way to determine the 
exact nature of the CS that has become associated with drug delivery in a drug user. 
Even if all of these cues were identified, it would be extremely difficult to extinguish 
each one of them. In addition, some studies suggest that extinction is not a mechanism 
by which the subject unlearns the association between the cue and drug delivery but 
rather creates a new association in which the cue no longer predicts the availability of 
the drug (Bouton, 2004). Data also suggest that as the original association is still 
intact, it may easily be reconditioned with a single re-pairing of the drug and its cue 
(Leri and Rizos, 2005) or through a variety of other manipulations. In this case, it is 
likely that after repeated drug-free sessions in the formerly drug-paired environment 
the animal has learned that this environment no longer predicts the availability of 
drug.  Similarly, rats who had prior exposure to the conditioning chamber did not 
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develop the conditioned response as readily as those animals that had no prior 
exposure.  In this instance, the animal is less likely to develop a conditioned response 
to the drug-paired environment because the animal had previously learned that this 
environment is irrelevant.  The fact that this learned irrelevance must be overcome 
before conditioning can occur is the basis for latent inhibition.  These findings are 
particularly important because they validate the effects of exposure to a heroin-paired 
environment on iNOS induction as a true form of classical conditioning and 
demonstrate two methods of reducing the conditioned response.   
 The biological mechanisms underlying conditioned alterations in immune 
status are currently under investigation but several paradigms have revealed an 
involvement of the opioid system.  For example, Lysle et al. (1992) demonstrated that 
the reduction in NK cell activity and lymphocyte mitogenic responses observed 
following exposure to cues that had previously been paired with aversive shock are 
mediated by the actions of endogenous opioids.  Further experimentation revealed that 
these conditioned immune alterations were specifically mediated via centrally located 
mu-opioid receptors (Lylse & Perez, 1997).  The conditioned effects of heroin on 
immune functioning may be mediated through similar mechanisms, however, these 
effects may also involve components of the CNS that have been implicated in 
addiction and conditioned responses to drug cues.  Interestingly, human brain imaging 
data has shown changes in neural activity within specific brain regions following 
exposure to drug cues in former drug users (Sell et al. 2000).  In addition, research has 
demonstrated an increase in c-Fos expression in the lateral habenula, basolateral 
amygdala complex, prelimbic cortex,  and nucleus accumbens core in rats exposed to 
drug-associated CS (Miller & Marshall 2005; Zhang et al. 2005).  Animal research 
employing pharmacological manipulations further supports the contribution of these 
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areas to cue-induced drug seeking behavior (See 2005; Rizos et al. 2005; Fuchs et al. 
2005).  Given that these brain areas appear to play a role in the acquisition and 
expression of conditioned responses to drug cues it is possible that the conditioned 
effects of heroin on immune status may also be mediated through activation of some 
of the same neural circuitry.  Regardless of the mechanism, it is important to take into 
account the profound immune alterations that occur upon exposure to drug-related 
stimuli and to consider how the various manipulations that reduce these effects might 
impact the immune system’s response to disease.  
  
 
 
 
CHAPTER 3 
 
CONDITIONED EFFECTS OF HEROIN ON PROINFLAMMATORY 
MEDIATORS REQUIRE THE BASOLATERAL AMYGDALA 
 
Introduction 
 The data presented in Chapter 2 indicated that exposure to a previously-heroin 
paired environment will elicit reductions in nitric oxide expression similar to what is 
observed with actual heroin administration.  In addition, these conditioned effects are 
susceptible to both extinction and latent inhibition indicating that this is a true form of 
classical conditioning.  The studies described in Chapter 3 will determine whether 
other proinflammatory mediators, such as the cytokines TNF-α and IL-1β, may also 
be conditioned to environmental stimuli associated with drug administration.  In 
addition, the role of the basolateral amygdala in the expression of heroin’s 
conditioned effects on these immune parameters will be examined.   
 Heroin addiction is a chronic, debilitating disorder marked by high incidence 
of relapse despite repeated rehabilitation efforts.  Exposure to drug cues is one of the 
key contributing factors to relapse mainly because these cues induce a wide variety of 
complex, classically conditioned physical and behavioral responses (Unnithan et al 
1992; Derbas et al 2001). There has been increasing evidence from studies conducted 
on human subjects showing that drug-paired stimuli can cause intense craving, 
feelings of being ‘high’, galvanic skin responses, autonomic arousal, and altered 
neural activity in drug users (Sideroff & Jarvik 1980; Ehrman et al. 1992; Foltin & 
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Haney 2000).  These data suggest that exposure to drug-associated stimuli may have 
effects similar to administration of the drug itself. Several investigators have shown 
that many of the physiological and behavioral responses to opioids, such has heroin 
and/or morphine, may be conditioned to previously drug-paired stimuli.  For example, 
environmental stimuli that had previously been paired with morphine administration 
can elicit such morphine-like effects as hyperthermia when presented in the absence 
of morphine (Bardo & Valone, 1994; Eikelboom & Stewart, 1979; Miksic et al., 
1975; Schwarz & Cunningham, 1990; Wikler & Pescor, 1967).  Similar results have 
been seen with the conditioning of morphine’s analgesic properties such that exposure 
to morphine-associated stimuli induces a conditioned analgesic response in the 
absence of drug (Miller et al 1990; Bardo & Valone 1994).  Current research in the 
area of drug addiction has focused on the critical task of reducing relapse by 
attempting to curb cue-induced drug seeking behavior, however, it is also imperative 
to take into account the widespread effects these cues may have on immune 
functioning and the ability of previous drug users to combat infectious disease while 
in recovery.   
Research in our laboratory and others has shown that not only will 
administration of heroin suppress a number of basic immune parameters but many of 
these suppressive effects on the immune system may also be conditioned to 
environmental cues that predict drug availability.  For instance, rats re-exposed to a 
previously morphine–paired environment display alterations in basic immune 
parameters similar to those seen upon actual morphine administration including 
decreased mitogen responsiveness of lymphocytes, decreased NK cell activity and 
suppressed IL-2 production (Coussons et al 1992; Saurer et al 2008).  In line with 
these studies, it has been shown that heroin administration results in a profound 
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reduction in LPS-induced nitric oxide expression (Lysle & How 2000) and this effect 
on nitric oxide may be conditioned to environmental stimuli that predict drug 
availability (Lysle & Ijames, 2002).  In addition to effects on nitric oxide, there is 
evidence that opiate administration may also alter the production of the pro-
inflammatory cytokines, TNF-α and IL-1β (Chao et al 1993; Pacifici et al 2000).  All 
three of these molecules are important components of the innate immune system 
which provides the first line of defense against invading pathogens.  Given the critical 
nature of these pro-inflammatory mediators in the initial response to infection it is 
imperative that we understand how heroin and heroin related cues may alter their 
effectiveness.     
  Little is known about the brain areas involved in these conditioned effects, 
however, the basolateral amygdala (BLA) has been implicated in the formation and 
expression of stimulus-reward associations within models of drug abuse.  For 
example, exposure to drug cues will reinstate drug seeking behavior in rats who have 
undergone extinction training (Gracy et al., 2000).  However, inactivation of the BLA 
will block the ability of these cues to reinstate drug seeking (McLauglin & See 2003; 
Fuchs et al 2005).  Interestingly, this same study did not show an effect of BLA 
inactivation on drug self-administration suggesting that the BLA is critical for 
conditioned but not unconditioned reinforcement (Meil & See, 1997).  Furthermore, 
animals receiving morphine injections paired with a distinct environment showed 
greater Fos activation within the BLA when re-exposed to that environment than 
animals receiving un-paired injections (Harris & Ashton-Jones, 2003).  Similarly, 
cocaine-associated cues elicited neural activity within the BLA nearly identical to that 
seen upon intravenous delivery of cocaine in rats taught to self-administer (Carelli et al., 
2003).  Taken together, these studies provide clear and consistent evidence supporting 
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the investigation of the BLA as part of the neurobiological circuitry involved in the 
conditioned immune responses to heroin.  
The data presented in Chapter 2 revealed that the conditioned effects of heroin 
on nitric oxide production constitute a true form of classical conditioning as these 
effects are susceptible to both extinction and latent inhibition.  The current set of 
experiments sought to establish the role of the basolateral amygdala, an area known to 
be involved in associative learning processes, in the conditioned effects of heroin on 
nitric oxide by quantifying iNOS expression in spleen and liver tissue following 
inactivation of the BLA.  In addition, IL-1β and TNF-α were measured in these same 
tissues to determine whether exposure to stimuli previously paired with heroin would 
alter the expression of these cytokines and if inactivation of the BLA would have an 
effect on these conditioned alterations.  
Materials and Methods 
Animals 
Male Lewis rats, weighing 225-250 g, were purchased from Charles River 
Laboratories (Raleigh, N.C., USA).  Upon arrival, animals were housed individually 
in plastic cages in a colony room with a reversed light-dark (12h) cycle maintained 
through artificial illumination.  Animals were allowed access to food and water ad 
libitum throughout the experiment except for the time spent in the conditioning 
chambers when food and water were not available.  All animals were given a 2-week 
habituation period before the start of experimental manipulations and were handled 
regularly during this time.  All procedures described were approved by the IACUC of 
the University of North Carolina at Chapel Hill and conformed to National Institutes 
of Health (NIH) Guidelines on the Care and Use of Laboratory Animals. 
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Drug Administration 
Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD) and dissolved in 
0.9 % sterile saline.  For all experiments, animals received a subcutaneous injection of 
heroin at a dose 1 mg/kg immediately prior to placement in the conditioning chamber 
on each of the five conditioning trial days.  This dose was selected based on prior 
experiments in our laboratory showing that a 1 mg/kg dose of heroin alters LPS-
induced iNOS mRNA expression in spleen and liver tissue and induces conditioning 
(Lysle & How, 2000; Lysle & Ijames, 2002; Szczytkowski & Lysle, 2007).   
Surgeries and microinjections 
Animals were anesthetized with 0.35 ml intramuscular injections of 1:1 (vol/vol) 
ketamine hydrochloride (100 mg/ml) mixed with xylazine (20 mg/ml) and placed into 
the stereotaxic apparatus.  Animals were implanted with 26-gauge bilateral guide 
cannula (Plastics One, Roanoke, VA) directed towards the BLA (AP -2.5, ML±5.0, 
DV -6.6) or Caudate control region (AP -2.4, ML±4.5, DV -4.0).  Coordinates are 
expressed as millimeters from bregma (Paxinos & Watson, 1986).   
 Animals were given a two week recovery period before the start of 
conditioning trials.  On test day, animals received bilateral intracranial injections (0.3 
µl/side infused over 1 min) of saline vehicle or a combination of GABA agonists, 
muscimol (0.03 nmol)/baclofen (0.3 nmol), 30 minutes prior to re-exposure to the 
conditioning chambers to determine whether the brain areas inactivated are necessary 
for the conditioned alterations in pro-inflammatory mediators.  Injectors extended 2 
mm beyond the tip of the cannula and were left in place for 1 minute after the 
injection to allow for proper infusion.  
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Procedures 
Acquisition of conditioned response. All animals received five 60-min training 
sessions in which they were administered a subcutaneous injection of heroin (1 
mg/kg) upon placement into a standard conditioning chamber which served as the 
conditioned stimulus.  Training sessions were separated by 48 hours.  The 
conditioning chambers (BRS/LVE, Laurel, Md., USA) were contained in a room 
separate from the animal colony.  Chambers were fitted with a metal grid floor design 
and cedar bedding to create an environment distinct from that of the home cage and to 
provide both olfactory and tactile cues for conditioning.  All conditioning took place 
during the dark phase of the light cycle and the conditioning chambers were kept dark 
to minimize effects on circadian rhythms.   
 
Table 3.1: Schematic representation of the behavioral and pharmacological 
manipulations employed for each treatment group. 
 
Testing of expression of conditioned response.  The test day took place six days 
following the final conditioning session.  Thirty minutes prior to testing, two groups 
of animals (Mus/Bac-BLA; Mus/Bac-Caud) received intra-BLA (or intra-caudate) 
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microinfusions of the combination of GABA agonists, muscimol and baclofen, to 
temporarily inactivate the BLA (or caudate).  Control animals received intra-BLA (or 
intra-caudate) microinfusions of saline vehicle (Saline-BLA; Saline-Caud).  To test 
the expression of the conditioned response, two groups of animals were re-exposed to 
the conditioned stimulus (i.e.; the conditioning chambers) without drug to determine 
whether the conditioned stimulus alone would induce alterations in pro-inflammatory 
mediators.  Animals re-exposed to the conditioning chambers on test day are indicated 
in the figures as CS.  The remaining animals (home cage, HC) were returned to the 
home cage following microinfusions and served as controls.  Experimental treatment 
of each group is outlined in Table 3.1.  After the 60-min re-exposure, the animals 
were removed from the chambers and given a subcutaneous injection of LPS (1000 
µg/kg) to induce iNOS production in spleen and liver tissue.  Home cage animals also 
received LPS at this time.  Six hours after LPS administration all animals were 
sacrificed and samples of spleen, liver and blood were collected for analysis.  The 6-
hr timepoint was selected based on previous research in our laboratory showing 
maximal iNOS induction at six hours following LPS administration (Lysle & How, 
2000).   
Real Time RT-PCR  
To determine iNOS expression, real time RT-PCR was performed on tissue samples 
from the spleen and liver.  A detailed description of this procedure is provided in 
Chapter 2.   
ELISA 
For IL-1β and TNF-α protein determinations, protein was extracted from a section of 
each tissue using freeze/thaw lysis in tris-buffer containing antiproteinases.  Protein 
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was quantified spectrophotometrically (Bio-Tek, Model EL312 kinetic reader, 
Winooski, VT, USA) using Bio-Rad protein dye.  The BioSource International, Inc. 
(Carlsbad, CA) rat IL-1β and TNF-α ELISA test kits were used to determine the 
levels of IL-1β or TNF-α protein in each tissue sample.  Briefly, samples and 
standards were added to microtiter wells coated with antibody that recognizes IL-1β 
or TNF-α and incubated at room temperature.  Wells were washed extensively and 
then incubated with biotinylated antibody, followed by a second wash and then 
incubation with Streptavidin-HRP.  After the final washing, a chromagen substrate 
solution was added which reacted with the bound enzyme to produce color.  The color 
intensity developed proportionally to the amount of IL-1β or TNF-α present in each 
sample.  The enzyme reaction was stopped after 30 minutes, and the absorbance at 
450 nm was measured with a Bio-Tek (Winooski, VT) Model EL312 kinetic reader.  
A standard curve was obtained by plotting the absorbance versus the corresponding 
concentrations of the supplied standards. 
Nitrite/Nitrate Assay 
The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent 
assay.  A detailed description of this procedure is provided in Chapter 2.   
Statistical Analysis 
Analysis of variance was performed on all data sets.  When the overall ANOVA 
showed significant effects, post hoc comparisons were made using Tukey’s test to 
compare individual treatment groups. All analyses were conducted with the level of 
significance set at p < 0.05.  
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Histology 
To confirm proper cannula placement Alcian blue dye was infused via the cannula 
following sacrifice.  Brains were then extracted and post-fixed in a 4% 
paraformaldehyde solution.  Following fixation the brains were transferred to a 30% 
sucrose solution for cryoprotection and then frozen at -80o C until further analysis.   
Coronal sections (50 µm) were taken and stained with cresyl violet for verification of 
cannula placement.  Animals with cannula placement outside of the targeted region 
were removed from the analyses.  Figure 3.1 shows a schematic diagram illustrating 
the most ventral point of the injection cannula for each animal in the study.  Figure 
3.2 is a representative photomicrograph showing the injection cannula tract to the 
BLA.   
 
Figure 3.1: BLA injection cannula placement was verified by cresyl violet stained 
coronal sections.  Symbols in the diagram represent the most ventral point of the 
injection cannula for each animal in the study based on the atlas of Paxinos and 
Watson (1998).  AP coordinates indicate the distance from bregma in mm.  (CS, 
Saline-black circles; CS, Mus/Back-gray circles; HC, Saline-black squares; HC, 
Mus/Bac-gray squares) 
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Figure 3.2: Representative photomicrograph showing the cannula tract and site of 
injection within the BLA on a cresyl violet stained coronal section.  The arrow 
indicates the most ventral point of the injector cannula tract. 
 
Results 
Effect of BLA Inactivation on Conditioned Nitric Oxide Suppression 
The first study investigated the effect of temporary inactivation of the BLA on 
the expression of heroin-induced conditioned suppression of nitric oxide production.  
Six days following the final conditioning session, animals were divided into groups 
with one group being re-exposed to the previously heroin-paired environment for 60 
min (Conditioned Stimulus, CS) while the other group remained in the home cage and 
served as controls (Home Cage, HC).  In order to temporarily inactivate the brain 
regions under investigation, animals in the Mus/Bac-BLA and Mus/Bac-Caud groups 
received microinfusions of the muscimol/baclofen combination directly into the BLA 
or Caudate, respectively, 30 minutes prior to testing.  The animals in the Saline-BLA 
and Saline-Caud groups received microinfusions of saline into these same areas.   
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Figure 3.3: Effect of treatments on LPS-induced expression of iNOS mRNA in the 
spleen and liver as determined by real-time RT-PCR. Data are expressed as iNOS 
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler 
software.  (*) Asterick indicates a significant difference (p<0.05) from the HC (Home 
cage), Saline-BLA/Caud group. 
 
 Figure 3.3 (panels A & C) shows the results of each treatment on LPS-induced 
expression of iNOS mRNA in the spleen and liver following inactivation of the BLA.  
Analysis of iNOS copy number in spleen and liver revealed a significant main effect 
of treatment [F(4,15)=10.711, P<0.01; F(4,15)=9.432, p<0.01].  Moreover, there was 
a significant difference in iNOS mRNA copy number between the animals exposed to 
the conditioned stimulus on test day who had received intra-BLA saline (CS, Saline-
BLA) and the animals who remained in the home cage on test day and received intra-
BLA saline (HC, Saline-BLA). These differences were evident in both tissues 
(p<0.05) which supports our earlier findings indicating that exposure to a previously 
heroin-paired environment alters the expression of iNOS mRNA.  Most importantly, 
there were no significant differences between the HC, Saline-BLA group and the 
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experimental group that received intra-BLA microinjections of muscimol/baclofen 
before exposure to the conditioned stimulus on test day (CS, Mus/Bac-BLA) 
demonstrating the ability of BLA inactivation to reduce the conditioned response.  
Furthermore, there were no significant differences between the HC, Saline-BLA 
group and the group that received intra-BLA muscimol and baclofen but remained in 
the home cage on test day (HC, Mus/Bac-BLA) indicating that these results are 
specific to administration of drug and not due to ancillary effects of the 
microinjections.  There were also no differences found in expression of the 
housekeeping gene, cyclophilin, between any of the groups indicating that the 
alterations in mRNA were specific for iNOS and not the result of an overall reduction 
in RNA expression or production (data not shown).   
 Figure 3.3 (panels B & D) also shows the effects of each treatment on LPS-
induced expression of iNOS mRNA in the spleen and liver following administration 
of the muscimol/baclofen comebination into a control region of the caudate.  Analysis 
of iNOS copy number in spleen and liver revealed a significant main effect of 
treatment [F(4,15)=6.458, p<0.05; F(4,15)=6.868, p<0.01].  Planned comparisons 
revealed a significant difference between the CS, Saline-Caud group and the HC, 
Saline-Caud group in both tissues (p<0.05) which is in agreement with the data from 
our previous research.  Most importantly, there was also found to be a significant 
difference between the HC, Saline-Caud group and the experimental group that 
received intra-caudate microinjections of muscimol/baclofen that was re-exposed to 
the conditioned stimulus on test day (CS, Mus/Bac-Caud) indicating that inactivation 
of this region does not alter the heroin-induced conditioned reduction of iNOS 
(p<0.05).  Furthermore, there were no significant differences between the HC, Saline-
Caud group and the HC, Mus/Bac-Caud group indicating that these results are 
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specific to administration of drug and not due to ancillary effects of the 
microinjections.   
 
 
Figure 3.4: Effect of treatments on serum nitrite/nitrate levels as determined by the 
Greiss reagent assay.  The data are expressed as the micromolar concentration of 
nitrite/nitrate.  (*) Asterick indicates a significant difference (p<0.05) from the HC 
(Home cage), Saline-BLA/Caud group. 
 
The data in Figure 3.4 show the effects of BLA (A) or caudate control region 
(B) inactivation on serum nitrite/nitrate levels.  Nitrite and nitrate are byproducts of 
nitric oxide production and levels of these markers serve as an indirect analysis of 
nitric oxide levels in the blood.  For the BLA inactivation experiment, examination of 
nitrite/nitrate levels in the serum revealed a significant main effect of treatment 
[F(4,15)=13.939, p<0.01] and a significant difference between the CS, Saline-BLA 
group and the HC, Saline-BLA group (p<0.05) indicating that exposure to a 
previously heroin paired environment reduces the production of nitric oxide.  There 
were no significant differences between the HC, Saline-BLA group and the CS, 
Mus/Bac-BLA group demonstrating that inactivation of the BLA reduces the 
conditioned effects of heroin on nitric oxide.  Taken together, these findings show that 
inactivation of the BLA will reduce the conditioned effects of heroin on nitric oxide 
production.   
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 For the caudate control region experiment, analysis of variance revealed a 
significant main effect of treatment [F(4,15)=16.767, p<0.01] and a significant 
difference between both the CS, Saline-Caud group and the HC, Saline-Caud group 
(p<0.01) and the CS, Mus/Bac-Caud group and the HC, Saline-Caud group (p<0.01).  
These results indicate that exposure to a previously heroin-paired environment 
reduces the production of nitric oxide and this effect is not attenuated by inactivation 
of this region of the caudate.   
 
BLA inactivation and the conditioned suppression of pro-inflammatory 
cytokines 
            Figure 3.5 shows that the suppressive effect of heroin on the pro-inflammatory 
cytokine, IL-1β, can be conditioned to environmental stimuli and this conditioned 
effect is reduced by inactivation of the BLA.  This effect was evident at both the 
protein and mRNA level and in both spleen and liver tissue.  Analysis revealed a main 
effect of treatment on both mRNA and protein levels in the spleen [F(4,15)=6.546, 
p<0.01; F(4,15)=38.871, p<0.01] and liver [F(4,15)=7.993, p<0.01;  F(4,15)=21.964, 
p<0.01].  In line with our previous experiments, the CS, Saline-BLA group exhibited 
significantly lower levels of IL-1β mRNA and protein in both the spleen and liver 
(p<0.05) as compared to the HC, Saline-BLA group.  The CS, Mus/Bac-BLA group 
was not significantly different from the HC, Saline-BLA group indicating that 
inactivation of the BLA was able to reverse the conditioned effects of heroin on IL-1β 
mRNA and protein expression.   
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Figure 3.5: Effect of treatments on LPS-induced expression of IL-1β mRNA and 
protein in the spleen (A, C) and liver (B, D) as determined by real-time RT-PCR. The 
RT-PCR data (A, B) are expressed as IL-1β copy number per 10 ng cDNA based on a 
standard curve using Roche LightCycler software.  The ELISA data (C, D) are 
expressed as picograms of protein per ml.  (*) Asterick indicates a significant 
difference (p<0.05) from the HC (Home cage), Saline-BLA group. 
 
   Figure 3.6 shows that the suppressive effect of heroin on the proinflammatory 
cytokine IL-1β is not altered by inactivation of the caudate control region. As the time 
of tissue collection was optimized for iNOS analysis it is not surprising that there was 
no significant effect at this timepoint in liver IL-1β mRNA levels. As the effect is 
evident at the protein level this suggests that it might also have been present at the 
mRNA level at an earlier timepoint. Analysis revealed a main effect of treatment on 
both mRNA and protein levels in the spleen [F(4,15) = 20.141, P < 0.01; 
F(4,15) = 21.585, P < 0.01] and on protein in the liver [F(4,15) = 7.993, P < 0.01]. In 
line with our previous experiments, the CS Saline-Caud group exhibited significantly 
lower levels of IL-1β mRNA and protein in the spleen and in protein in the liver  
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Figure 3.6 Effect of treatments on LPS-induced expression of IL-1β mRNA and 
protein in (A and C) the spleen and (B and D) liver as determined by real-time RT-
PCR. Re-exposure to the previously heroin-paired environment (CS) reduced IL-1β 
mRNA and protein in the spleen and IL-1β protein in liver tissue, and this reduction 
was not altered by inactivation of the caudate control region. (A and B) The RT-PCR 
data are expressed as IL-1β copy number per 10 ng cDNA based on a standard curve 
using Roche LightCycler software. (C and D) The ELISA data are expressed as pg of 
protein per ml. *P < 0.05 vs. the HC Saline-Caud group. 
 
(P < 0.05) as compared to the HC Saline-Caud group. The CS Mus/Bac-BLA group 
also exhibited significantly lower IL-1β protein and mRNA (except for liver mRNA 
which showed the same trend but was not significant) compared with the HC Saline-
Caud group, indicating that inactivation of the caudate control region was not able to 
reverse the conditioned effects of heroin on IL-1β mRNA and protein expression. 
            Figure 3.7 shows that the suppressive effect of heroin on the pro-inflammatory 
cytokine, TNF-α, can also be conditioned to environmental stimuli and, again, this 
conditioned effect is reduced by inactivation of the BLA.  This effect was evident at 
both the protein and mRNA level in the spleen and liver with the exception of TNF-α  
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Figure 3.7 Effect of treatments on LPS-induced expression of TNF-α mRNA and 
protein in (A and C) the spleen and (B and D) the liver as determined by real-time 
RT-PCR. The RT-PCR data are expressed as TNF-α copy number per 10 ng cDNA 
based on a standard curve using Roche LightCycler software. (C and D) The ELISA 
data are expressed as pg of protein per mL. *P < 0.05 vs. the HC Saline-Caud group. 
 
mRNA in the liver.  As with IL-1β, the lack of a significant effect in liver TNF-α 
mRNA is not surprising and the significance at the protein level suggests that an 
effect may have been evident at an earlier timepoint.  Analysis revealed a main effect 
of treatment on both mRNA and protein levels in the spleen [F(4,15)=6.946, p<0.01; 
F(4,15)=27.644, p<0.01] and on protein levels in the liver [F(4,15)=7.313, p<0.01].  
In line with our previous experiments, the CS, Saline-BLA group exhibited 
significantly lower levels of TNF-α mRNA in the spleen (p<0.05) and significantly 
lower levels of TNF-α protein in both the spleen and liver (p<0.05) when compared to 
the HC, Saline-BLA group.   
          Figure 3.8 shows that the suppressive effect of heroin on the pro-inflammatory 
cytokine, TNF-α, is not altered by inactivation of the caudate control region.  The  
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Figure 3.8: Effect of treatments on LPS-induced expression of TNF-α mRNA and 
protein in the spleen (A, C) and liver (B, D) as determined by real-time RT-PCR. The 
RT-PCR data (A, B) are expressed as TNF-α copy number per 10 ng cDNA based on 
a standard curve using Roche LightCycler software.  The ELISA data (C, D) are 
expressed as picograms of protein per ml.  (*) Asterick indicates a significant 
difference (p<0.05) from the HC (Home cage), Saline-Caud group. 
 
suppressive effect of conditioning was evident at both the protein and mRNA level.  
Analysis revealed a main effect of treatment on both mRNA and protein levels in the 
spleen [F(4,15)=7.605, p<0.01.; F(4,15)=7.779, p<0.01] and liver [F(4,15)=11.494, 
p<0.01; F(4,15)=12.655, p<0.01].  In line with our previous experiments, the CS, 
Saline-Caud group exhibited significantly lower levels of TNF-α mRNA and protein 
in the spleen and in the liver when compared to the HC, Saline-Caud group.  
Inactivation of the caudate control region had no effect on this suppression as the CS, 
Mus/Bac-Caud group also showed significantly lower levels of TNF-α protein and 
mRNA as compared to the HC, Saline-Caud group (p<0.05). 
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Discussion 
 Previous research in our laboratory has shown that exposure to a previously 
drug-paired environment induces alterations in nitric oxide production similar to those 
observed upon actual drug administration (Lysle & Ijames, 2002; Szczytkowski & 
Lysle, 2007).  The data presented here are the first to demonstrate that the suppressive 
effects of heroin on the pro-inflammatory cytokines, TNF-α and IL1-β, may also be 
conditioned to environmental stimuli.  Both Interleukin-1 beta (IL-1β) and Tumor 
necrosis factor-alpha (TNF-α) are pro-inflammatory cytokines involved in host 
defense.  When secreted, both IL-1β and TNF-α have widespread effects in the host 
including altering the thermoregulatory setting in the hypothalamus to produce fever 
and increasing the expression of adhesion factors on endothelial cells to promote the 
transmigration of leukocytes to sites of infection.  In addition, it appears that both 
TNF-α and IL-1β are highly involved in LPS-induced septic shock.  Rats with LPS-
induced septic shock exhibited a peak in TNF-α mRNA in plasma at one hour post-
infection with levels beginning to decline by two hours after LPS administration.  
Similarly, IL-1β peaked at one hour post-LPS and gradually returned to baseline over 
nine hours (Lin et al, 2006).  The samples collected in this study were taken at 6 hours 
post-LPS injection to optimize for LPS-induced nitric oxide production.  The ability 
of these manipulations to detect a significant change in IL-1β and TNF-α 
demonstrates the robustness of these effects.  Furthermore, given the time course of 
these effects the fact that some of the data failed to reveal significant differences 
between treatment groups in levels of TNF-α or IL-1β mRNA in the liver is not 
surprising.  However, the significant reduction in TNF-α and IL-1β protein in liver 
tissue detected by the ELISA suggests that mRNA levels for these cytokines may 
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have been previously suppressed in the group that was re-exposed to the conditioned 
stimulus on test day but may have rebounded by the 6-hour timepoint at which they 
were analyzed.      
Given the multifaceted and complex involvement of these cytokines, as well 
as nitric oxide, in the initial immune response to infectious challenge it is essential to 
understand the mechanisms and neural circuitry through which heroin’s conditioned 
alterations of these pro-inflammatory mediators are controlled.  The results presented 
here provide the first evidence that inactivation of the BLA can reduce or even 
eliminate the conditioned suppressive effects of heroin on nitric oxide induction and 
on the expression of the pro-inflammatory cytokines, TNF-α and IL-1β.  This 
attenuation appears to encompass several organ systems as it is found in both spleen 
and liver tissues as well as in serum levels of nitrite/nitrate.  In addition, the 
attenuation is apparent at both the mRNA and protein levels showing that the 
expression as well as the production of these mediators is altered.  The use of several 
control groups further demonstrates that these results are specific to the manipulations 
used and not related to ancillary effects of the conditioning or surgical procedures.  
Moreover, in order to ensure that these results were specific to the BLA, a control 
experiment was conducted in which an area of the caudate situated dorsal to the BLA 
was also injected with the combination of GABA agonists. The inactivation of this 
region of the caudate did not produce an attenuation of the conditioned response 
demonstrating that the results are specific to the BLA.  These findings are consistent 
with prior investigations showing that heroin-induced alterations in immune status 
may be conditioned to drug-paired stimuli (Lysle & Ijames, 2002) and that these 
alterations are indeed a form of associative learning as they are susceptible to both 
extinction and latent inhibition (Szczytkowski & Lysle, 2007).  In these previous 
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investigations, animals received subcutaneous injections of heroin upon placement in 
a distinctive environment.  Upon re-exposure to that environment, in the absence of 
drug, the subjects exhibited a reduction in nitric oxide production similar to what is 
observed with heroin treatment.  Repeated exposure to the distinctive environment 
without drug, either pre- (latent inhibition) or post-conditioning (extinction) abolished 
this conditioned effect.   The present study extends these previous findings by 
showing that the basolateral amygdala, an area known to be involved in associative 
learning processes, is required for the expression of these conditioned effects.    
 These results suggest that there exists a neural circuit, of which the BLA is an 
integral component, which mediates these conditioned alterations in immune 
measures.  Given the wealth of research showing the involvement of the BLA in 
conditioned responses, it is not surprising that this area would be required for the 
expression of conditioned suppression of pro-inflammatory mediators. Numerous 
investigators have demonstrated a role of the BLA in associative learning.  For 
example, lesions of the BLA block acquisition of classical eye blink conditioning 
(Blankenship et al., 2005), inhibit conditioned fear responses to aversive stimuli in 
rats (Lee et al.,  2005), and block acquisition of the motivational value of an appetitive 
US (Setlow et al., 2002).  In addition, learning of an inhibitory avoidance task 
involves neuronal activity within the BLA (Chang et al., 2005) as does olfactory fear 
conditioning (Sevelinges et al., 2004) and conditioning of odorant attractiveness in 
female mice (Moncho-Bogani et al., 2005). Furthermore, the BLA has been 
implicated in the formation of new, and in the utilization of already established, 
stimulus-reward associations within models of drug abuse.  For example, inactivation 
of the BLA inhibits the reacquisition of heroin seeking in a test of conditioned place 
preference (Rizos et al., 2005).   Similarly, it has been demonstrated that inactivation 
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of the BLA abolishes the expression of CS-induced reinstatement of heroin-seeking 
behavior in rats (Fuchs & See, 2002).  In addition, it has been shown that animals 
receiving morphine paired with a distinct environment exhibit Fos protein expression, 
a marker of neural activation, within both the BLA and the central nucleus of the 
amygdala during a test of conditioned place preference (Harris & Ashton-Jones, 
2003).   
 The exact mechanism through which conditioned drug cues exert their effects 
on pro-inflammatory mediators remains unknown as does the means by which the 
BLA alters these effects.  Studies suggest that it is unlikely the BLA itself has a direct 
effect on immune parameters as lesions and/or inactivation of this area do not seem to 
induce changes in immune reactivity (Jurkowski et al 2001; Grijalva et al 1990).   
This is consistent with the data reported here since inactivation of the BLA, by itself, 
did not alter the induction of pro-inflammatory mediators.  While the BLA may not 
directly alter immune parameters, previous work in our laboratory and others has 
shown several brain areas to which the BLA is connected that have direct effects on 
the immune system including the central amygdala and the nucleus accumbens.  For 
instance, Hayley et al (2002) reported increased monoamine utilization in the central 
amygdala in response to systemic administration of TNF-a suggesting that this area of 
the amygdala is sensitive to peripheral changes in cytokine production.  In addition, 
research has shown that systemic LPS administration induces c-fos expression in the 
central amygdala (Rivest & LaFlamme, 1995; Sagar et al 1995; Tkacs & Li, 1999) 
and infusion of dopamine D1 agonists directly into this area results in increased Con-
A stimulated splenocyte proliferation (Nistico et al 1994; Caroleo et al 1998).  The 
BLA sends extensive projections to the central amygdala and the communication 
between these two areas is thought to create a circuit by which many conditioned 
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responses are mediated (Pare et al 1995; Royer et al 1999; Likhtik et al 2008).  
Likewise, studies have shown that interactions between the BLA and the nucleus 
accumbens may be necessary for the establishment and expression of some 
conditioned responses including cocaine seeking induced by conditioned drug cues 
(Setlow et al, 2002; Di Ciano & Everitt, 2004). In addition, infusion of dopamine D1 
antagonists into the nucleus accumbens shell blocks morphine-induced suppression of 
NK cell cytotoxicity while infusion of a D1 agonist recreates this suppression (Saurer 
et al 2006). These data suggest that dopamine activity within the nucleus accumbens 
is both necessary and sufficient for the induction of immune alterations.  Since 
inactivation of the BLA attenuates the conditioned effects of heroin on pro-
inflammatory mediators it is possible that information regarding the conditioned 
stimulus is routed through the BLA to the nucleus accumbens and it is actually the 
nucleus accumbens that directly influences immune alterations.   
   Considering the increased susceptibility to infection that occurs with opioid 
use it is possible that the conditioned alterations in certain immune parameters that 
occur in response to exposure to drug-paired cues might also compromise immune 
function and increase susceptibility to disease.  The host’s initial response to an 
immune challenge is a complex and highly regulated process.  Some of the key 
mediators involved in the initial response to potential pathogens are inducible nitric 
oxide, IL-1β, and TNF-α.  Each of these immune system components is responsible 
for numerous processes that together make up the response that is necessary to 
combat infectious agents and to prepare the site of infection for repair and recovery.  
These results are important, not only because they provide the first demonstration that 
the suppression of pro-inflammatory cytokines can be conditioned to environmental 
stimuli paired with heroin administration, but also because they demonstrate that the 
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expression of the conditioned effects of heroin on pro-inflammatory mediators require 
the basolateral amygdala.  These effects and the brain areas that control them need to be 
factored into the comprehensive treatment of opiate users.  
  
 
 
 
CHAPTER 4 
 
THE ROLE OF DOPAMINE IN HEROIN-INDUCED CONDITIONED 
IMMUNOMODULATION 
 
Introduction 
 
 The results presented in chapters 2 and 3 indicated that exposure to 
environmental stimuli previously paired with heroin administration will elicit 
alterations in immune paramaters and these conditioned effects are attenuated by  
inhibition of the basolateral amygdala.   Those findings suggest that the basolateral 
amygdala is an integral component of the circuit mediating the conditioned effects of 
heroin on proinflammatory mediators.  The current chapter further explores the role of 
basolateral amygdala by examining the dopaminergic inputs to this brain region and 
their involvement in the expression of heroin-induced conditioned 
immunomodulation.   
 Interestingly, the dopaminergic system within the BLA has been shown to be 
involved in learning and memory and specifically the associative learning that underlies 
classical conditioning.  For example, intra-amygdalar 6-hydroxydopamine injections 
impaired (Ashford & Jones, 1976), while post-training intra-BLA dopamine infusions 
enhanced (LaLumiere et al., 2004) memory consolidation of a conditioned avoidance 
task.  In addition, rats with 6-hydroxydopamine lesions of the amygdala exhibit 
impaired acquisition of conditioning to explicit cues (Selden et al., 1991).  
Microdialysis studies revealed an increase in dopamine and its metabolites during the 
learning of a discriminative task in rats (Hori et al., 1993) further supporting the 
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importance of this neurotransmitter in BLA-mediated learning and memory.  
Furthermore, Macedo et al. (2007) demonstrated that antagonism of dopamine D1 
receptors within the BLA reduces the expression of conditioned, but not 
unconditioned, fear.   
 Dopaminergic signaling within the BLA appears to be particularly important 
for the associative learning processes that accompany the acquisition and expression 
of conditioned responses to drugs of abuse.  For example, intra-BLA administration of 
D-amphetamine potentiates cue-induced cocaine seeking possibly by increasing 
monoamine tone in this region (Ledford et al., 2003).  In addition, site specific 
adminstration of a dopamine D1/D2/D3 antagonist  into the basolateral amygdala, but 
not the central amygdala, blocks alcohol-induced conditioned place preference in 
mice (Gremel & Cunningham, 2008).  More specifically, stimulation of dopamine D1 
receptors in the BLA was found to be necessary for the expression of cue-induced 
reinstatement of cocaine-seeking behavior in rats (See et al., 2001; Yun & Fields, 
2003).  In contrast, dopamine D2 receptors in the BLA appear to be involved in the 
acquisition of associations between drugs of abuse and the conditioned cues that guide 
subsequent cue-induced drug-seeking behavior (Berglind et al., 2006).  These findings 
provide a strong rationale for examining the involvement of the dopaminergic system 
within the BLA on the expression of heroin-conditioned immunomodulation.  In 
addition, dopamine has been implicated in the immunosuppression caused by 
morphine administration.  Saurer et al. (2004) demonstrated that the dopamine D1 
receptor antagonist SCH23390 administered into the accumbens shell attenuates 
morphine-induced suppression of NK cell activity.   
 The current set of experiments sought to establish the role of the dopaminergic 
system within the basolateral amygdala in the conditioned effects of heroin on nitric 
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oxide by quantifying iNOS expression in spleen and liver tissue following antagonism 
of dopamine (D1 or D2) receptors in the BLA.  In addition, IL-1β and TNF-α were 
measured in these same tissues to determine whether exposure to stimuli previously 
paired with heroin would alter the expression of these cytokines and if dopamine 
antagonism would have an effect on these conditioned alterations.  The findings 
reported here are important because they indicate that previously heroin-associated 
environmental stimuli are not only capable of inducing alterations in proinflammatory 
mediators but that these effects may be modified by antagonism of specific 
dopaminergic receptors within the BLA.   
 
Materials and Methods 
Animals 
Male Lewis rats, weighing 225-250 g, were purchased from Charles River 
Laboratories (Raleigh, N.C., USA).  Upon arrival, animals were housed individually 
in plastic cages in a colony room with a reversed light-dark (12h) cycle maintained 
through artificial illumination.  Animals were allowed access to food and water ad 
libitum throughout the experiment except for the time spent in the conditioning 
chambers when food and water were not available.  All animals were given a 2-week 
habituation period before the start of experimental manipulations and were handled 
regularly during this time.  All procedures described were approved by the IACUC of 
the University of North Carolina at Chapel Hill and conformed to National Institutes 
of Health (NIH) Guidelines on the Care and Use of Laboratory Animals. 
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Drug Administration 
Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD) and dissolved in 
0.9 % sterile saline.  For all experiments, animals received a subcutaneous injection of 
heroin at a dose 1 mg/kg immediately prior to placement in the conditioning chamber 
on each of the five conditioning trial days.  This dose was selected based on prior 
experiments in our laboratory showing that a 1 mg/kg dose of heroin alters LPS-
induced iNOS mRNA expression in spleen and liver tissue and induces conditioning 
(Lysle & How, 2000; Lysle & Ijames, 2002; Szczytkowski & Lysle, 2007).   
Surgeries and microinjections 
Animals were anesthetized with 0.35 ml intramuscular injections of 1:1 (vol/vol) 
ketamine hydrochloride (100 mg/ml) mixed with xylazine (20 mg/ml) and placed into 
the stereotaxic apparatus.  Animals were implanted with 26-gauge bilateral guide 
cannula (Plastics One, Roanoke, VA) directed towards the BLA (AP -2.5, ML±5.0, 
DV -6.6).  Coordinates are expressed as millimeters from bregma (Paxinos & Watson, 
1986).   
 Animals were given a two week recovery period before the start of 
conditioning trials.  On test day, animals received bilateral intracranial injections (0.5 
µl/side infused over 1 min) of saline vehicle, the D1 antagonist, SCH23390 (2 µg/0.5 
µl/side) or the D2 antagonist, raclopride (5 µg/0.5 µl/side) 30 minutes prior to re-
exposure to the conditioning chambers.  These doses were chosen based upon 
previous behavioral studies that had shown effects upon administration of these doses 
into the BLA (Berglind et al, 2005; See et al, 2001).  Injectors extended 2 mm beyond 
the tip of the cannula and were left in place for 1 minute after the injection to allow 
for proper infusion.     
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Histology 
 
To confirm proper cannula placement Alcian blue dye was infused via the cannula 
following sacrifice.  Brains were then extracted and post-fixed in a 4% 
paraformaldehyde solution.  Following fixation the brains were transferred to a 30% 
sucrose solution for cryoprotection and then frozen at -80o C until further analysis.   
Coronal sections (50 µm) were taken and stained with cresyl violet for verification of 
cannula placement.  Animals with cannula placement outside of the targeted region 
were removed from the analyses.   
Procedures 
Acquisition of conditioned response. All animals received five 60-min training 
sessions in which they were administered a subcutaneous injection of heroin (1 
mg/kg) upon placement into a standard conditioning chamber which served as the 
conditioned stimulus.  A detailed description of these training sessions is provided in 
Chapters 2 and 3.    
 Testing of expression of conditioned response.  The test day took place six 
days following the final conditioning session.  To test the expression of the 
conditioned response, animals were re-exposed to the conditioned stimulus (i.e.; the 
conditioning chambers) without drug to determine whether the conditioned stimulus 
alone would induce alterations in pro-inflammatory mediators.  Thirty minutes prior 
to testing, animals received intra-BLA microinfusions of either the D1 antagonist, 
SCH23390, or the D2 antagonist, raclopride.  Control animals received intra-BLA 
microinfusions of saline vehicle.  Two groups of animals were then re-exposed to the 
chambers (conditioned stimulus, CS) for 60-min without further administration of 
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heroin.  The remaining animals (home cage, HC) were returned to the home cage 
following microinfusions and served as controls.  After the 60-min re-exposure, the 
animals were removed from the chambers and given a subcutaneous injection of LPS 
(1000 µg/kg) to induce iNOS, TNF-α and IL-1β production.  Home cage animals also 
received LPS at this time.  Six hours after LPS administration all animals were 
sacrificed and samples of spleen, liver and blood were collected for analysis.  The 6-
hr timepoint was selected based on previous research in our laboratory showing 
maximal iNOS induction at six hours following LPS administration (Lysle & How, 
2000).   
Real Time RT-PCR  
To determine iNOS expression, real time RT-PCR was performed on tissue samples 
from the spleen and liver.  A detailed description of this procedure is provided in 
Chapter 2.   
ELISA 
For IL-1β and TNF-α protein determinations, protein was extracted from a section of 
each tissue using freeze/thaw lysis in tris-buffer containing antiproteinases.  A 
detailed description of this procedure is provided in Chapter 3. 
Nitrite/Nitrate Assay 
The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent 
assay.  A detailed description of this procedure is provided in Chapter 2.   
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Statistical Analysis 
Analysis of variance was performed on all data sets.  When the overall ANOVA 
showed significant effects, post hoc comparisons were made using Tukey’s test to 
compare individual treatment groups. All analyses were conducted with the level of 
significance set at p < 0.05.  
Results 
D1 Receptor Antagonism 
 
The first study investigated the effect of intra-BLA microinfusion of the D1 receptor 
antagonist, SCH23390, on the expression of heroin-induced conditioned suppression 
of proinflammatory mediators.  Six days following the final conditioning session, 
animals were divided into groups with one group being re-exposed to the previously 
heroin-paired environment for 60 min (Conditioned) while the control groups 
remained in the home cage.  In order to temporarily block the receptors under 
investigation, animals in the SCH23390 groups received microinfusions of the 
SCH23390 compound directly into the BLA 30 minutes prior to testing of the 
conditioned response.  The animals in the saline-treated groups received 
microinfusions of saline into these same areas.  
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Figure 4.1: Effect of treatments on LPS-induced expression of iNOS mRNA in the 
spleen and liver as determined by real-time RT-PCR. Data are expressed as iNOS 
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler 
software.  
 
 Figure 4.1 shows the mean levels of LPS-induced iNOS mRNA expresssion in 
the spleen and liver for each group of animals.  Analysis of iNOS copy number in 
spleen and liver, respectively, revealed a significant main effect of group 
[F(4,15)=13.716, P<0.01; F(4,15)=16.883, p<0.01].  Moreover, post-hoc analyses 
revealed a significant difference in iNOS mRNA copy number between the saline-
treated animals exposed to the conditioned stimulus on test day (Conditioned, white 
bars) and the animals who remained in the home cage on test day (Control, black 
bars). These differences were evident in both tissues (p<0.05) which reconfirms our 
earlier findings indicating that exposure to a previously heroin-paired environment 
suppresses the expression of iNOS mRNA.  Most importantly, there were no 
significant differences between the saline-treated control group (Saline, black bars) 
and the SCH-treated conditioned group (SCH23390, black bars) for either tissue.  
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These results demonstrate that antagonism of dopamine D1 receptors in the BLA 
blocks the conditioned effects of a previously heroin-paired environment on iNOS 
mRNA expression.  
 
Figure 4.2: Effect of treatments on serum nitrite/nitrate levels as determined by the 
Greiss reagent assay.  The data are expressed as the micromolar concentration of 
nitrite/nitrate.   
 
 
 The data in Figure 4.2 show levels of serum nitrite/nitrate levels for each 
group. The ANOVA revealed a significant main effect of procedure [F(4,15) = 9.416, 
P<0.01] on the levels of nitrite/nitrate in the serum. Post-hoc analyses revealed a 
significant difference between the saline-treated animals exposed to the conditioned 
stimulus on test day (Conditioned, white bars) and the animals who remained in the 
home cage on test day (Control, black bars) (p<0.05).  These results further support 
our earlier findings that exposure to a previously heroin-paired environment decreases 
serum nitrite/nitrate levels, indicating a reduction in nitric oxide production. There 
were no significant differences between the SCH23390-treated group exposed to the 
conditioned stimulus on test day and the saline-treated control group indicating that  
the antagonism of dopamine D1 receptors in the BLA attenuated the conditioned 
response. There were also no differences between the saline-treated control group and 
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the SCH23390-treated control group indicating that administration of SCH23390 
alone does not alter nitrate levels in the serum.  
 
 
Figure 4.3 Effect of treatments on LPS-induced expression of IL-1β mRNA in the 
spleen and liver as determined by real-time RT-PCR. Data are expressed as IL-1β 
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler 
software.  
 
 
 Figure 4.3 illustrates that the suppressive effect of heroin on mRNA levels of 
the pro-inflammatory cytokine, IL-1β, can be conditioned to environmental stimuli 
and this conditioned effect may be reduced by antagonism of dopamine D1 receptors 
within the BLA.  Analysis revealed a significant main effect of treatment on mRNA 
levels in the spleen [F(4,15)=6.794, p<0.01] and liver [F(4,15)=8.929, p<0.01].  In 
line with our previous experiments, the saline-treated conditioned group exhibited 
significantly lower levels of IL-1β mRNA in both the spleen and liver (p<0.05) as 
compared to the saline-treated control group.  Most importantly, the SCH-treated 
conditioned group was not significantly different from the saline-treated control group 
for either tissue indicating that inactivation of the BLA was able to attenuate the 
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conditioned effects of heroin on IL-1β mRNA.  There were also no significant 
differences between the SCH-treated control group and the saline-treated control 
group indicating that SCH-treatment alone did not have an effect on IL-1β mRNA 
levels in the spleen or liver.  
 
Figure 4.4 Effect of treatments on LPS-induced expression of IL-1β protein in the 
spleen and liver as determined by real-time RT-PCR.  Data are expressed as pg of 
protein per ml.  
 
 Figure 4.4 shows that the results for IL-1β protein levels in spleen and liver 
tissue are similar to those seen for IL-1β mRNA levels.  Analysis revealed a main 
effect of treatment on protein levels in the spleen [F(4,15)=9.675, p<0.01] and liver 
[F(4,15)= 3.567, p<0.05].  As expected, the saline-treated conditioned group exhibited 
significantly lower levels of IL-1β protein in both the spleen and liver (p<0.05) as 
compared to the saline-treated control group.  In addition, the SCH-treated 
conditioned group was not significantly different from the saline-treated control group 
for either tissue similar to the results seen with IL-1β mRNA levels.  There were also 
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no significant differences between the SCH-treated control group and the saline-
treated control group.  
 
Figure 4.5: Effect of treatments on LPS-induced expression of TNF-α mRNA and 
protein in the spleen and liver as determined by real-time RT-PCR. The data are 
expressed as TNF-α copy number per 10 ng cDNA based on a standard curve using 
Roche LightCycler software.   
 
Figure 4.6: Effect of treatments on LPS-induced expression of TNF-α protein in the 
spleen and liver as determined by ELISA. The data are expressed as pg of protein per 
mL.  
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 Figures 4.5 and 4.6 shows that the suppressive effect of heroin on the 
proinflammatory cytokine, TNF-α, may be conditioned to environmental stimuli and, 
again, this conditioned effect is reduced by antagonism of dopamine D1 receptors 
within the BLA.  This effect was evident at the mRNA and protein level in both 
spleen and liver tissue.  Analysis revealed a main effect of treatment on mRNA and 
protein, respectively, in both spleen [F(4,15)=6.415, p<0.01; F(4,15)=9.027, p<0.01] 
and liver [F(4,15)=7.313, p<0.01; F(4,15)=3.538, p<0.05].  In line with our previous 
experiments, the saline-treated group exposed to the conditioned stimulus on test day 
exhibited significantly lower levels of TNF-α mRNA and protein in the spleen and 
liver (p<0.05) when compared to the saline-treated control group.  In addition, there 
were no significant differences between the saline-treated control group and either of 
the SCH-treated groups.   
 
D2 Receptor Antagonism 
The second study investigated the effect of intra-BLA microinfusion of the D2 
receptor antagonist, raclopride, on the expression of heroin-induced conditioned 
suppression of proinflammatory mediators.  The experimental design followed that of 
the D1 receptor antagonist study with one group being re-exposed to the previously 
heroin-paired environment for 60 min on test day while the control groups remained 
in the home cage.  In order to temporarily block the dopamine D2 receptors within the 
BLA, animals in the raclopride-treated groups received microinfusions of the D2 
antagonist directly into the BLA 30 minutes prior to testing of the conditioned 
response.  The animals in the saline-treated groups received microinfusions of saline 
into the same area.  
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Figure 4.7: Effect of treatments on LPS-induced expression of iNOS mRNA in the 
spleen and liver as determined by real-time RT-PCR. Data are expressed as iNOS 
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler 
software.  
 
 Figure 4.7 shows the mean levels of LPS-induced iNOS mRNA expresssion in 
the spleen and liver for each group of animals.  Analysis of iNOS copy number in 
spleen and liver, respectively, revealed a significant main effect of group 
[F(4,15)=6.625, P<0.01; F(4,15)=7.682, p<0.01].  Moreover, post-hoc analyses 
revealed a significant difference in iNOS mRNA copy number between the saline-
treated animals exposed to the conditioned stimulus on test day (Conditioned, white 
bars) and the animals who remained in the home cage on test day (Control, black 
bars). These differences were evident in both tissues (p<0.05) which reconfirms our 
earlier findings indicating that exposure to a previously heroin-paired environment 
suppresses the expression of iNOS mRNA.  Interestingly, there was also a significant 
difference between the saline-treated control group and the raclopride-treated 
conditioned group for both tissues.  These results indicate that antagonism of 
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dopamine D2 receptors in the BLA  does not alter the conditioned effects of a 
previously heroin-paired environment on iNOS mRNA expression. 
 
Figure 4.8: Effect of treatments on serum nitrite/nitrate levels as determined by the 
Greiss reagent assay.  The data are expressed as the micromolar concentration of 
nitrite/nitrate.   
 
 The data in Figure 4.8 shows the mean levels of serum nitrite/nitrate for each 
experimental group. The ANOVA revealed a significant main effect of procedure 
[F(4,15) = 5.442, P<0.05] on serum levels of nitrite/nitrate. Post-hoc analyses 
revealed a significant difference between the saline-treated animals exposed to the 
conditioned stimulus on test day and the animals who remained in the home cage 
(p<0.05).  These results are in line with our earlier experiments demonstrating that 
these effects may be conditioned to environmental stimuli. There was also a 
significant difference between the raclopride-treated group exposed to the conditioned 
stimulus on test day and the saline-treated control group indicating that the 
antagonism of dopamine D2 receptors in the BLA does not have an effect on the 
conditioned response to a previously heroin-paired environment.  
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Figure 4.9 Effect of treatments on LPS-induced expression of IL-1β mRNA in the 
spleen and liver as determined by real-time RT-PCR. Data are expressed as IL-1β 
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler 
software.  
 
 
Figure 4.10 Effect of treatments on LPS-induced expression of IL-1β protein in the 
spleen and liver as determined by real-time RT-PCR.  Data are expressed as pg of 
protein per ml.  
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 Figures 4.9 and 4.10 show that the suppressive effect of heroin on mRNA and 
protein levels of the pro-inflammatory cytokine, IL-1β, can be conditioned to 
environmental stimuli and this conditioned response is not altered by antagonism of 
dopamine D2 receptors within the BLA.  Analysis revealed a main effect of treatment 
on IL-1β mRNA levels in the spleen [F(4,15)=19.232, p<0.01] and liver 
[F(4,15)=5.601, p<0.05] as well as protein levels in the spleen [F(4,15)=34.440, 
p<0.01] and liver [F(4,15)=50.416, p<0.01].  In line with our previous experiments, 
the saline-treated conditioned group exhibited significantly lower levels of IL-1β 
mRNA and protein in the spleen and liver (p<0.05) as compared to the saline-treated 
control group.  Most importantly, the raclopride-treated conditioned group also 
displayed signicantly lower levels of IL-1β mRNA in the spleen and liver as 
compared to the saline-treated control group.  These data suggest that antagonism of 
doapmine D2 receptors within the BLA does not alter the conditioned effects of heroin 
on IL-1β mRNA levels.  There were also no significant differences between the 
raclopride-treated control group and the saline-treated control group indicating that 
raclopride-treatment alone did not have an effect on IL-1β mRNA or protein levels in 
the spleen or liver. 
 Figures 4.11 and 4.12 show that the heroin-induced conditioned suppression of 
the proinflammatory cytokine, TNF-α, is not affected by antagonism of dopamine D2 
receptors within the BLA.  Analysis revealed a main effect of treatment on mRNA 
and protein in the spleen [F(4,15)=6.442, p<0.01; F(4,15)=5.374, p<0.05] and on 
mRNA in the liver [F(4,15)=18.936, p<0.01].  In line with our previous experiments,  
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Figure 4.11 Effect of treatments on LPS-induced expression of TNF-α mRNA and 
protein in the spleen and liver as determined by real-time RT-PCR. The data are 
expressed as TNF-α copy number per 10 ng cDNA based on a standard curve using 
Roche LightCycler software.   
 
 
Figure 4.12 Effect of treatments on LPS-induced expression of TNF-α protein in the 
spleen and liver as determined by ELISA. The data are expressed as pg of protein per 
mL.  
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the saline-treated group exposed to the conditioned stimulus on test day exhibited 
significantly lower levels of TNF-α mRNA and protein in the spleen and TNF-α 
mRNA in the liver (p<0.05) when compared to the saline-treated control group.  In 
addition, the raclopride treated group that was re-exposed to the conditioned stimulus 
on test day also exhibited a conditioned reduction in TNF-α mRNA and protein in the 
spleen and mRNA in the liver as compared to the saline-treated control group 
(p<0.05). 
 
Discussion 
 The findings presented in the current chapter demonstrate that dopamine within 
the basolateral amygdala plays a critical role in the conditioned effects of heroin on 
proinflammatory mediators.  Specifically, these results revealed that antagonism of 
dopamine D1 receptors within the BLA blocks the expression of heroin-induced 
conditioned suppression of nitric oxide, TNF-α and IL-1β.  The SCH23390 compound 
has been used extensively as a selective D1 receptor antagonist and the dose of 2.0 
µg/side was chosen based upon an established literature showing an effect of this dose 
administered intra-BLA on cue-induced reinstatement to drug seeking (Berglind et al., 
2006; Alleweireldt et al., 2006).  Interestingly, selective antagonism of dopamine D2 
receptors within this same region does not appear to have any effect as the animals 
exposed to the conditioned stimulus and administered the antagonist still exhibited a 
conditioned suppression in proinflammatory mediators.  Collectively, these data 
indicate a role for dopamine D1, but not D2, receptors in the expression of heroin-
induced conditioned immunomodulation.  These data are in line with similar studies 
demonstrating that intra-accumbens SCH23390 blocks the effects of opioid drugs, and 
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stimuli associated with opioid drugs, on NK cell activity and nitric oxide production 
(Saurer et al., 2006; Saurer et al., 2009). 
 The mesolimbic dopamine system is known to be critically involved in the 
expression of the rewarding properties of drugs of abuse, including opiates.  In fact, 
heroin administration indirectly induces increased dopamine by the binding of its 
metabolites to mu-opioid receptors on GABA-ergic neurons within the ventral 
tegmental area.  Dopamine has also been widely implicated in the formation of 
memories underlying associative learning processes.  Specifically, dopamine and its 
receptors have been shown to mediate the learning of associations between drugs of 
abuse and their conditioned cues.  For example, microdialysis studies revealed an 
increase in dopamine and its metabolites during the learning of a discriminative task 
in rats (Hori et al., 1993) and upon the presentation of a stimulus that had previously 
been paired with cocaine administration (Weiss et al., 2000).  In addition, intra-
amygdalar 6-hydroxydopamine injections impaired (Ashford & Jones, 1976), while 
post-training intra-BLA dopamine infusions enhanced (LaLumiere et al., 2004) 
memory consolidation of a conditioned avoidance task.  Furthermore, intra-BLA 
infusions of amphetamine were found to potentiate cue-induced drug-seeking 
behavior following extinction (Ledford et al., 2003).  Taken together, these data 
suggest a role for dopamine in the BLA in heroin-induced classically conditioned 
immune alterations.   
The study of classical or Pavlovian conditioning allows for the dissociation of 
the associative processes underlying the acquisition of a learned response from the 
mechanistic control of the expression of the response itself.  In many cases these two 
phenomena are controlled via separate mechanisms.  For example, antagonism of 
beta-adrenergic receptor activity disrupts the expression but not the acquisition of 
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conditioned morphine-induced immune alterations (Coussons-Read et al., 1994).  The 
data reported here suggest that dopamine D1 receptors within the BLA are required 
for the expression of heroin’s conditioned effects on proinflammatory mediators.  
However, it is unknown whether D1 receptors within the BLA might also be involved 
in the acquisition of these responses and this presents an important area for future 
investigation.  Interestingly, there appears to be differential involvement of dopamine 
receptor subtypes within the BLA in the acquisition and the expression of responses to 
conditioned drug cues.  Several subtypes of dopamine receptors have been 
characterized and the BLA has been shown to express both D1- and D2-like receptors 
(Meador-Woodruff et al, 1991; Scibilia et al, 1992).  Macedo et al. (2007) 
demonstrated that antagonism of dopamine D1 receptors within the BLA reduces the 
expression of conditioned, but not unconditioned, fear.  In addition, stimulation of 
dopamine D1 receptors in the BLA is necessary for the expression of cue-induced 
reinstatement of cocaine-seeking behavior in rats (e.g., See et al., 2001; Yun & Fields, 
2003).  In contrast to the role of D1 receptors, D2 receptors in the BLA appear to be 
involved in the acquisition of associations between drugs and the cues that guide 
subsequent cue-induced cocaine-seeking behavior (Berglind et al., 2006).  There has 
also been evidence for the involvement of dopamine D3 receptors within the BLA as 
antagonism of these receptors was found to block reinstatement of drug seeking under a 
second-order schedule of reinforcement (Di Ciano, 2008).  Based on the evidence from 
these studies it might also be important to examine the potential role of dopamine D2 
and D3 receptors in the acquisition of associations between heroin and heroin-related 
cues that elicit immunomodulation. 
The BLA receives dopaminergic inputs from the ventral tegmental area (VTA) 
and substantia nigra as one of the main targets of the mesolimbic dopamine system 
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(Rosenkranz & Grace, 1999).  These inputs appear to be important for learning to 
associate the rewarding properties of drugs of abuse with external cues resulting in the 
ability of these drug cues to induce relapse to drug-seeking and other conditioned 
behaviors (DiCiano & Everitt, 2005; See, 2005).   The data reported here suggest that 
opioids and opioid-associated drug cues induce dopamine release from neurons 
originating in the VTA or substantia nigra which then binds to D1 receptors located 
within the BLA to influence the expression of conditioned responses to heroin related 
cues.  Research has shown that the primary targets of mesolimbic dopaminergic neuron 
inputs to the BLA are the dendrites of the pyramidal neurons (Muller et al., 2009).  
Within the BLA there exist two distinct neuronal cell populations, pyramidal and non-
pyramidal neurons.  The pyramidal neurons of the BLA primarily utilize glutamate as 
their neurotransmitter and exhibit spiny projections while the non-pyramidal cells rely 
heavily upon inhibitory GABA signals and show fewer spines (McDonald, 1992).  
Dopamine selectively increases the excitability of BLA pyramidal neurons allowing for 
potentiation of the inputs from other brain regions, such as the cortex (Pickel et al., 
2006).  Interestingly, the pyramidal cell glutamatergic projections from the BLA have 
been shown to synapse in close proximity to dopamine axons on medium spiny 
neurons of the nucleus accumbens (Johnson et al., 1994; Kelley et al., 1982; Robinson 
& Beart, 1988) thus giving rise to a complex interaction between dopamine and 
glutamate within these two brain regions.  In addition, electrophysiological studies 
have shown that tetanic stimulation of the BLA evokes dopamine efflux in the 
nucleus accumbens via glutamate receptor-dependent mechanisms localized within 
the accumbens (Floresco et al., 1998). Furthermore, either exogenously applied or 
synaptically released dopamine can modulate excitatory responses of nucleus 
accumbens neurons evoked by low frequency stimulation of the BLA (Yim & 
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Mogenson, 1982; 1986).   Collectively, these data suggest that the circuit 
encompassing the VTA, BLA and nucleus accumbens may be involved in the 
conditioned effects of heroin on immune measures.   
While it appears that the BLA does not directly impact immune functioning it is 
highly plausible that conditioned immune alterations may be induced through the 
connections of the BLA with the nucleus accumbens.  Saurer et al. (2006a) 
demonstrated that intra-accumbens shell administration of a dopamine D1 agonist 
resulted in decreased NK cell activity identifying this brain area as having the ability to 
directly induce immunomodulation.  It is as yet unknown what factors may be 
mediating these effects in the periphery but there is a wealth of data suggesting that the 
sympathetic nervous system may be involved.  For example, both primary and 
secondary lymphoid tissues have been found to be innervated by the sympathetic nerve 
fibers (Williams et al., 1981; Felten et al., 1984) and adrenergic receptors have been 
identified on the surface of immune cells (Livnat et al., 1985; Hori et al., 1997; 
Maestroni, 2006).  More specifically, peripheral administration of β-adrenergic 
antagonists has been shown to block the expression of the conditioned effects of 
morphine on several measurements of immune status (Coussons-Read et al., 1994).  
However, it appears that at least some of these immune alterations are mediated 
peripherally by neuropeptide Y as systemic administration of a neuropeptide Y Y1 
receptor antagonist dose-dependently attenuates morphine-induced alterations in NK 
cell activity while β-adrenergic antagonism had no effect (Saurer et al., 2006b).  These 
data seem to suggest differential mechanisms for the control of specific opioid-induced 
immune alterations.   
 It is important to understand the mechanisms by which heroin-induced 
conditioned immunomodulation occurs as these effects may have widespread 
 102
implications for the health of recovering addicts.  Nitric oxide, TNF-α and IL-1β are all 
components of the innate immune response and play critical roles in the host’s initial 
response to pathogenic challenge.  In the absence of a proper immune response, which 
may occur following exposure to drug-related cues, the host’s immune system may not 
be able to adequately deal with infection which may allow for increased pathogenic 
proliferation and sepsis.  The exact neural mechanism through which heroin-induced 
conditioned immunomodulation occurs is still not fully understood, but the data 
presented here suggests that the BLA plays a critical role.  The experiments reported 
here are the first to identify the dopaminergic D1 receptors within the BLA as crucial for 
the expression of the effects of heroin-related cues on immune functioning.  
  
 
 
 
CHAPTER 5 
 
GENERAL DISCUSSION 
 
Experimental Findings 
 Collectively, the present studies provide important new data regarding the 
neurobiological mechanisms by which heroin conditioned immunomodulation occurs.  
The investigation of conditioned responses to drug cues has led to significant 
advancements in our understanding and treatment of opiate addiction.  .  However, the 
conditioned immunomodulation that may occur upon exposure to these same drug 
cues and the implications that these changes in immune functioning have on 
susceptiblity to disease is a relatively neglected area of investigation.  The results of 
these studies suggest that exposure to heroin-paired stimuli can have a profound 
influence on the proinflammatory mediators of the innate immune system.  The 
implication is that former and current opiate users may be more susceptible to 
infection not only because of the direct action of opiates on target tissues but also 
because their body associates non-drug cues with changes in immunity.  The 
expression of these conditioned responses seem to be mediated by the same neural 
substrates found to be in control of other conditioned responses to drugs of abuse.   
 Previously published data (Lysle & Ijames, 2002) and the results presented in 
Chapter 2 show that the suppressive effects of heroin on proinflammatory mediators 
can be conditioned to environmental stimuli and confirms this conditioned response is 
an example of associative learning.  This conclusion is suppported by studies showing 
conditioned suppression in nitric oxide production is susceptible to the effects of both 
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extinction and latent inhibition.  Extinction is the reduction in a conditioned response 
observed following repeated exposure to the conditioned stimulus without the 
unconditioned stimulus.  Thus, extinction occurs when the conditioned stimulus no 
longer reliably predicts drug availability, and as result, the conditioned response is 
reduced.  Latent inhibition is the result of repeated exposure to the conditioned 
stimulus prior to the association of the conditioned stimulus with a drug; in latent 
inhibition, a subject must overcome the learned irrelevance of the stimlus in order to 
associate the stimulus with a physiological response.  The experiments in Chapter 2 
established that the conditioned responses observed upon exposure to a previously 
heroin-paired environment are a true example of classical conditioning by providing 
evidence of extinction and latent inhibition.  The results indicate that these 
conditioned responses involve associative learning processes which led to the 
investigation of the involvement of brain areas and neurotransmitter systems known 
play a role in learned associations between drugs of abuse and their cues.   
 Given the results of Chapter 2, Chapter 3 sought to explore the potential 
involvement of the basolateral amygdala (BLA) in the expression of the conditioned 
effects of heroin on nitric oxide.  The BLA is a critical component of the neural 
circuitry mediating conditioned responses to drugs of abuse.  Animals receiving 
morphine injections paired with a distinct environment showed greater Fos activation 
within the BLA when re-exposed to that environment than animals receiving un-paired 
injections (Harris & Ashton-Jones, 2003).  Similarly, cocaine-associated cues elicited 
neural activity within the BLA nearly identical to that seen upon intravenous delivery of 
cocaine in rats taught to self-administer the drug (Carelli et al., 2003).  Together, these 
and similar studies provide clear and consistent rationale supporting the investigation of 
the BLA as part of the neurobiological circuitry involved in the conditioned immune 
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responses to drugs of abuse, in general, and heroin, in particular.  In addition, the 
experiments in Chapter 3 demonstrate that the effects of heroin on peripheral TNF-α 
and IL-1β expression may be conditioned to enviroinmental stimuli.  Given the 
multifaceted and complex involvement of these cytokines, as well as nitric oxide, in 
the initial immune response to infectious challenge it is essential to understand the 
mechanisms and neural circuitry through which heroin’s conditioned alterations of 
these pro-inflammatory mediators are controlled.  The results from the experiments in 
Chapter 3 indicate that temporary inhibition of the BLA attenuates the conditioned 
effects of heroin on the proinflammatory mediators, nitric oxide, TNF-α and IL-
1β, thereby suggesting that the BLA may mediate these examples of 
neuroimmunomodulation in conditioned animals.   
 Chapter 4 demonstrates the role of dopamine receptors within the BLA for the 
conditioned effects of heroin on nitric oxide and the proinflammatory cytokines, TNF-
α and IL-1β.  Specifically, intra-BLA adminstration of the D1 receptor antagonist, 
SCH23390, reduced the conditioned response in animals exposed to a previously 
heroin-paired environment.  Conversely, intra-BLA administration of the D2 receptor 
antagonist, raclopride, had no effect on the conditioned response as animals receiving 
the drug and re-exposed to the conditioning chamber still exhibited significant 
conditioned reductions in nitric oxide, TNF-α and IL-1β.  These results are consistent 
with Saurer et al. (2008) in which conditioned morphine-induced alterations in natural 
killer (NK) cell activity were found to be mediated by dopamine D1 receptors in 
another brain region (the nucleus accumbens shell).  Interestingly, D1 receptors 
mediate the non-conditioned alterations in NK cell cytotoxity observed following 
morphine administration (Saurer et al., 2006).  Collectively, these data identify D1 
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receptors within the BLA as part of the circuitry that must be activated for the 
expression of heroin-induced conditioned immunomodulation.   
 
Neural Circuitry 
 The experiments outlined in this dissertation indicate a clear role for the BLA 
in mediating the expression of conditioned immune alterations observed upon 
exposure to a previously heroin-paired environment.  These data show that activation 
of dopamine  D1 receptors is necessary for the expression heroin-induced conditioned 
immunomodulation.  The circuitry mediating the conditioned effects of heroin related 
stimuli on immune paramaters may be similar to the circuitry mediating other 
conditioned responses to drugs of abuse.  Studies have shown that stimuli associated 
with drug use may acquire incentive-motivational properties and may elicit drug 
craving and/or seeking (Weiss, 2005; Sell et al., 2000).  Animal models such as the 
conditioned place preference test are used to observe these drug associated behaviors 
in rodents and to investigate the neural mechanisms by which these behaviors are 
controlled.  Through the use of these models several brain regions have been 
identified that may exist as part of a circuit mediating cue-induced drug seeking 
behavior; these regions include the prelimbic region of the prefrontal cortex, anterior 
cingulate cortex, the central and basolateral amygdala, the ventral tegmental area 
(VTA), hippocampus, hypothalamus and the nucleus accumbens (Zijlstra et al., 2009; 
Chaudhri et al., 2008; Hamlin et al., 2008; Kalivas & Volkow, 2005).   
 The VTA is especially important for mediating the rewarding properties of 
conditioned stimuli that have become associated with drugs of abuse.  For example, 
dopaminergic neurons in the VTA increase firing rates in response to reward-related 
conditioned stimuli (Kosobud et al., 1994) and increases in mesolimbic dopamine are 
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observed prior to the reinstatement of responding for reward (Gratton and Wise, 
1994).  The VTA is the primary source of mesolimbic dopamine which is found to be 
increased in VTA target regions, such as the nucleus accumbens and amygdala, 
following exposure to conditioned cues predicting drug availability (Ranaldi et al., 
1999;  Harmer & Phillips, 1999; Ito et al., 2000).  Potentiation of VTA dopaminergic 
neurons and increases in VTA dopaminergic transmission are attributed to intra-VTA 
glutamatergic activity as glutamate antagonists administered directly into the VTA, 
but not outside of it, inhibit the acquisition of conditioned place preference to drugs of 
abuse (Harris & Aston-Jones, 2003; Shabat-Simon et al., 2008).  In addition, it is 
possible that alterations in dopamine activity are controlled by the presence of 
glutamate receptors on the VTA dopaminergic neurons as glutamate receptors have 
been implicated in the control of persistent cocaine seeking behaviors (Engblom et al., 
2008).  However, Engblom et al. (2008) focused on unconditioned cocaine seeking 
behavior and it is not clear whether conditioned drug seeking behavior would utilize 
this same mechanism.  A potential caveat is that the activation of glutamate receptors 
on VTA dopaminergic neurons may be specific to the pharmacodynamic properties of 
cocaine and may not be generalizable to other drugs of abuse.  Nevertheless, the 
dopaminergic connections between the VTA and its targets are important for 
mediating conditioned responses to all drugs of abuse.   
 The research presented here as well as by others elucidates a role for the BLA 
in the conditioned responses to drugs of abuse.  For example, exposure to drug cues 
will reinstate drug seeking behavior in rats even after extinction training (Gracy et al., 
2000) and inactivation of the BLA will block the ability of these cues to reinstate drug 
seeking (McLauglin & See 2003; Fuchs et al 2005).  Interestingly, there was no effect 
of BLA inactivation on self-administration suggesting that the BLA is critical for 
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conditioned but not unconditioned reinforcement (Meil & See, 1997).  It is likely that 
while the connections between the VTA and the nucleus accumbens modulate the 
unconditioned effects of drug administration, the circuits connecting the VTA to the 
BLA and the BLA to the nucleus accumbens may mediate the conditioned responses to 
drug cues.  In fact, the BLA is one of the main targets of the mesolimbic dopaminergic 
system and receives numerous projections from the VTA (Brinley-Reed & 
McDonald, 1999).  The BLA also receives input from the prefrontal cortex and 
stimulation of the medial prefrontal cortex results in activation of BLA GABAergic 
neurons and a reduction in BLA neuronal excitability which is reversed by the 
presence of dopamine (Grace & Rosenkranz, 2002).   Thus, these two BLA circuits 
appear to differentially modulate the plasticity of the BLA and its outputs.  In 
addition, glutamatergic projections from the BLA synapse in close proximity to 
dopaminergic neurons of the nucleus accumbens (Johnson et al., 1994).   
 The nucleus accumbens, one of the other main targets of VTA dopaminergic 
neurons, is another brain structure that has been widely established as critical for 
conditioned responses to stimuli associated with drug abuse.  The nucleus accumbens 
receives dopaminergic inputs from cells originating in the VTA as well as the 
glutamatergic projections from the BLA.  The neural circuitry from the VTA to the 
BLA and the BLA to the nucleus accumbens appears to especially important for the 
acquisition and expression of conditioned responses to addictive drugs.  In support of 
this, pharmacologically disconnecting the BLA from the nucleus accumbens reduces 
cue-induced drug seeking (Di Ciano & Everitt, 2004).  This was accomplished by 
antagonizing the dopamine receptors within the BLA to block the influence of VTA 
dopaminergic input on one side of the brain while simultaneously antagonizing the 
glutamatergic input from the BLA to the nucleus accumbens on the contralateral side.  
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Interestingly, the nucleus accumbens may be part of the circuitry mediating opiate-
induced conditioned immune alterations (Saurer et al., 2008).  In addition, the 
accumbens appears to be involved in the regulation of peripheral immune measures as 
lesions or pharmacological manipulations of mesoaccumbens dopaminergic neurons 
result in altered immune reactivity (Deleplanque et al., 1994; Nistico et al., 1994).  
Furthermore, both conditioned and unconditioned effects of morphine appear to be 
mediated via dopamine D1 receptors in the nucleus accumbens as antagonism of these 
receptors block morphine- and morphine-associated stimuli induced suppression of 
NK cell activity (Saurer et al., 2006a; Saurer et al., 2008).  An investigation of the 
contribution of the VTA-BLA-accumbens circuit in conditioned immune alterations 
seen upon exposure to heroin-related stimuli will be an important next step in 
modeling the neurobiology of addiction and addiction-related changes in physiology.   
 
Peripheral Mediators 
 While the exact peripheral mechanisms modulating the alterations in 
proinflammatory mediators observed in response to exposure to opioid-associated 
drug cues are unknown, research has revealed potential roles for several 
neuroendocrine factors.  The sympathetic nervous system innervates both primary and 
secondary lymphoid tissues and releases molecules that interact with receptors on 
immune cells (Williams et al., 1981; Felten et al., 1984).  In fact, sympathetic 
innervation of the spleen, provides some of the most concrete evidence for 
communication between the nervous and immune systems through sympathetic 
nervous system release of norepinephrine (and other chemicals) from nerve fibers 
onto immune cells in this organ.  In addition, several researchers have indicated a role 
for the sympatehtic nervous system for the expression of conditioned immune 
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alterations.  For example, the immunosuppressive effects of cyclosporine A can be 
conditioned to a gustatory stimulus and this conditioned effect is blocked by 
denervation of the spleen (Exton et al., 1998).  Previous research from our laboratory 
shows that the suppression of splenic mitogenic responsiveness observed following 
exposure to a conditioned aversive stimulus can be blocked by administration of the 
beta-adrenergic receptor antagonist, propanolol (Lysle et al., 1991).  Furthermore, the 
sympathetic nervous system may also be involved in the direct effects of morphine on 
immunity as both selective and non-selective beta-adrenergic receptor antagonists 
attenuate the suppressive effects of morphine administration on select measures of 
lymphocyte proliferation (Fecho et al., 1993).  Other experimentation reveals that 
both the conditioned and unconditioned effects of opiates on the cytotoxicity of NK 
cells appears to be mediated by neuropeptide Y, a peptide transmitter co-released with 
norepinephrine by the sympathetic nervous system (Saurer et al. 2006; 2008).   In 
addition, the expression of a subset of morphine-induced conditioned immune 
alterations are blocked by the systemic administration of the non-selective peripheral 
β-adrenergic receptor antagonist, nadolol (Coussons-Read et al., 1994).  Collectively 
these data suggest a role for the sympathetic nervous system in the modulation of 
opiate-induced conditioned immunomodulation. 
 Hypothalamic-pituitary-adrenal (HPA) axis activiation may result in 
alterations in immune functioning through the release of hormones from the 
hypothalamus, pituitary and adrenal gland.  Stress is a potent activator of the HPA 
axis and is immunomodulatory in part through stress-mediated release of 
corticotropin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), and 
glucocorticoids (from the hypothalamus, pituitary, and adrenal, respecitvely).  For 
instance, psychological stress in animals induces decreases in the immune cytokine 
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interferon-gamma and these decreases are reversed when the animals are treated with 
a glucocorticoid receptor antagonist (Curtin et al., 2009)  HPA axis factors are also 
involved in with some instances of conditioned immune alterations.  For example, 
exposure to a stimulus previously paired with LPS administration induces suppression 
of IL-2 production concomitantly with increases in circulating corticosterone (Janz et 
al., 1996) and exposure to a stimulus previously associated with an electic shock 
treatment elicits reductions in NK cell activity as well as increases in plasma 
corticosterone.  However, HPA axis activation may not be necessary for the 
expression of all conditioned immunological effects (Perez & Lysle, 1995) as the 
effects on NK cell activity are blocked by adminstration of a CRH antagonist while 
the effects on plasma corticosterone are not.  Instead, CRH may be acting through 
alternative immunomodulatory pathways.  One possibility is the locus coeruleus 
which is activated by CRH and CRH adminstration into this brain region results in 
decreases in T-lymphocyte mitogenic responses that are associated with decreases in 
antibody production (Rassnick et al., 1994).  In regard to conditioned 
immunomodulation,  cocaine-associated cues induce alterations in immune 
functioning, including TNF-α production, and these alterations accompany elevations 
in corticosterone levels suggesting the HPA axis may be involved in drug cue 
mediated conditioned immunomodulation (Kubera et al., 2008).   
 A third possible drug cue mediated conditioned immunomodulation is the 
endogenous opioid system.  As mentioned previously, exposure to a conditioned 
stimulus previously paired with electrical shock results in the suppression of a number 
of immune parameters including NK cell activity, mitogen-induced lymphocyte 
proliferation and the number of antibody producing cells (Lysle et al., 1988; Lysle et 
al., 1990).  These effects appear to be mediated by opioid receptors in the brain as 
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systemic administration of the opioid antagonist, naltrexone, but not N-
methylnaltrexone5 results in an attenuation (Lysle et al., 1992).  More specifically, 
reductions in immunity are mediated by mu-opioid receptors as 
intracerebroventricular administration of a mu-1 selective opioid receptor antagonist, 
but not a kappa- or delta- selective antagonist, blocks electrical shock-induced 
conditioned alterations in immunity (Perez & Lysle, 1997).  Both the acquisition and 
the expression of morphine-induced conditioned suppression of immune functioning 
are attenuated by antagonism of opioid receptors, suggesting endogenous opioids play 
a role in opioid-induced conditioned immunomodulation (Coussons-Read et al., 
1994).  While the mechanisms underlying the conditioned effects of opiate drugs on 
immunity remain unknown, there are several possibilities as indicated by the wealth 
of data surrounding the mediators of conditioned responses to non-drug related 
stimuli.  The continued search for the exact peripheral mediators modulating the 
conditioned effects of opioid drugs on immune paramaters is critical for 
understanding how to control these effects in recovering addicts and reduce the 
susceptibility to infection in these individuals.   
   
General Conclusions 
 There is a substantial literature indicating that heroin use has a profound, 
negative impact on clinical health outcomes.  Given the widespread use of illicit 
heroin, as well as the clinical use of other opioids, it is important to understand not 
only the direct effects of these chemicals on target tissues but also the mechanisms 
underlying the conditioned effects of these drugs on physiological processes, 
                                                 
5 N-methylnaltrexone is a quaternary form of naltrexone that does not readily cross the blood-brain 
barrier 
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including immune functioning.  The experiments in this dissertation are among the 
first to show that exposure to stimuli previously associated with heroin use may not 
only contribute to relapse but may also alter the ability of the host’s immune system 
to respond to an infectious agent.  In addition, the data provide new and revealing 
information regarding the neural circuitry underlying Pavlovian conditioning 
processes, specifically those in which the unconditioned stimulus is a potentially 
addictive drug.  Furthermore, as the capacity to learn associations between drug 
administration and environmental stimuli is shared by virtually all drug related 
conditioned responses, the results from these studies suggest mechanistic pathways 
for how stimuli associated with drugs such as cocaine, amphetamine, and alcohol may 
change on immune responses, i.e., by acting within or through systems associated 
with the basolateral amygdala. 
   Much of the current research examining the mechanism of drug addiction and 
treatment focuses on reducing relapse by attenating cue induced drug seeking 
behavior. However, it is imperative to consider the immunomodulatory effects drug 
cues can have on immune functioning.  The results presented here provide the first 
evidence for a neurological circuit mediating the immunologic alterations associated 
with drug cues paired with heroin administration. Drugs users are not only influenced 
by the action of drugs on target cells, but drug users are also influenced by unique (to 
each user) drug-associated cues. As drug-associated cues can be immunomodulatory 
and are often immunosupressive. This suggests drug users (and recovering addicts) 
may experience alterations in their ability to combat infectious diseases even in the 
absence of drugs.  The user-specific nature of these results suggests the host response to 
opioids is not be static, but will change as the organism learns to anticipate drug 
adminstration.  It follows that recovering drug addicts may be at an increased risk for 
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developing opportunistic infections as well as for other problems from decreased 
immunity such as improper antibody responses to vaccination.  These effects need to 
be factored into the comprehensive treatment of both current and former opiate users. 
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